kw1	kw2	pg	crit_p	edge_weight	inv_edge_weight	R1C1	iteration
carbolines/pharmacology	antioxidants/pharmacology	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	piperazines/pharmacology	0.004842334459021824	0.008584933923434476	0.11931818181818181	0.49585123021520294	1	2
carbolines/pharmacology	raw 264.7 cells	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	dose-response relationship drug	6.136951791191336e-08	3.271929188673207e-07	0.001893939393939394	0.18259996156874114	2	2
carbolines/pharmacology	microglia/drug effects	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	methotrexate/pharmacology	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	vitamin e/pharmacology	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	cystine/antagonists &amp; inhibitors	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	lipopolysaccharides/toxicity	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	inflammation mediators/antagonists &amp; inhibitors	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	oxidative stress	0.004006594837651867	0.007247331657780852	0.11931818181818181	0.49585123021520294	1	2
carbolines/pharmacology	tetrahydrofolate dehydrogenase/genetics	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	folic acid antagonists/pharmacology	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	nf-e2-related factor 2/biosynthesis	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
carbolines/pharmacology	gene expression	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
antioxidants/pharmacology	cell proliferation/drug effects	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
antioxidants/pharmacology	piperazines/pharmacology	0.0002396003701709004	0.0006063146082656577	0.06060606060606061	0.49585123021520294	1	2
antioxidants/pharmacology	dose-response relationship drug	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
antioxidants/pharmacology	methotrexate/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
antioxidants/pharmacology	vitamin e/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
antioxidants/pharmacology	jurkat cells	0.0005236625778490822	0.0011135397157585613	0.06060606060606061	0.49585123021520294	1	2
antioxidants/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
antioxidants/pharmacology	cystine/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
antioxidants/pharmacology	oxidative stress	0.00017732562798067342	0.0004688852858464707	0.06060606060606061	0.49585123021520294	1	2
antioxidants/pharmacology	tetrahydrofolate dehydrogenase/genetics	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
antioxidants/pharmacology	folic acid antagonists/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
antioxidants/pharmacology	gene expression regulation neoplastic	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	phenols/chemistry	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	aldehydes/chemistry	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	proto-oncogene proteins c-akt/metabolism	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	chemokine ccl3/genetics	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	cyclopentane monoterpenes	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	AKT1	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	CCL3	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	MAPK3	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	methotrexate/pharmacology	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	vitamin e/pharmacology	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	cystine/antagonists &amp; inhibitors	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	oxidative stress	0.005566454437330726	0.009630849740778557	0.11931818181818181	0.49585123021520294	1	2
cell proliferation/drug effects	tetrahydrofolate dehydrogenase/genetics	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	multiple myeloma/drug therapy	0.005566454437330726	0.009630849740778557	0.11931818181818181	0.49585123021520294	1	2
cell proliferation/drug effects	folic acid antagonists/pharmacology	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
cell proliferation/drug effects	gene expression regulation neoplastic/drug effects	0.005566454437330726	0.009630849740778557	0.11931818181818181	0.49585123021520294	1	2
triple negative breast neoplasms/drug therapy	HLF	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
triple negative breast neoplasms/drug therapy	IL6	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
triple negative breast neoplasms/drug therapy	JAK2	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
triple negative breast neoplasms/drug therapy	SMAD3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
triple negative breast neoplasms/drug therapy	STAT3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
triple negative breast neoplasms/drug therapy	TGFB1	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
triple negative breast neoplasms/drug therapy	tumor-associated macrophages/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
triple negative breast neoplasms/drug therapy	drug resistance neoplasm	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
triple negative breast neoplasms/drug therapy	basic-leucine zipper transcription factors/analysis	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
triple negative breast neoplasms/drug therapy	GGT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
HLF	tumor-associated macrophages/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
HLF	basic-leucine zipper transcription factors/analysis	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
HLF	drug resistance neoplasm	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
HLF	IL6	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
HLF	JAK2	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
HLF	SMAD3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
HLF	STAT3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
HLF	TGFB1	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
HLF	GGT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
IL6	tumor-associated macrophages/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
IL6	basic-leucine zipper transcription factors/analysis	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
IL6	drug resistance neoplasm	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
IL6	JAK2	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
IL6	GGT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
IL6	SMAD3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
IL6	STAT3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
IL6	TGFB1	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	phospholipid hydroperoxide glutathione peroxidase	3.3210735916888723e-07	1.5224173801153195e-06	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	dose-response relationship drug	0.004842334459021824	0.008584933923434476	0.11931818181818181	0.49585123021520294	1	2
piperazines/pharmacology	methotrexate/pharmacology	0.0002396003701709004	0.0006063146082656577	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	iron/blood	3.3210735916888723e-07	1.5224173801153195e-06	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	vitamin e/pharmacology	0.0002396003701709004	0.0006063146082656577	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	jurkat cells	0.005704538562607997	0.009846602340032455	0.11931818181818181	0.49585123021520294	1	2
piperazines/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	0.0002396003701709004	0.0006063146082656577	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	spleen/pathology	3.3210735916888723e-07	1.5224173801153195e-06	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	cystine/antagonists &amp; inhibitors	0.0002396003701709004	0.0006063146082656577	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	glutathione	3.3210735916888723e-07	1.5224173801153195e-06	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	liver/pathology	3.3210735916888723e-07	1.5224173801153195e-06	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	oxidative stress	0.0027480089335699676	0.00504515925857543	0.11931818181818181	0.49585123021520294	1	2
piperazines/pharmacology	tetrahydrofolate dehydrogenase/genetics	0.0002396003701709004	0.0006063146082656577	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	malondialdehyde/blood	3.3210735916888723e-07	1.5224173801153195e-06	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	kidney	3.3210735916888723e-07	1.5224173801153195e-06	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	folic acid antagonists/pharmacology	0.0002396003701709004	0.0006063146082656577	0.06060606060606061	0.49585123021520294	1	2
piperazines/pharmacology	gene expression regulation neoplastic	0.004842334459021824	0.008584933923434476	0.11931818181818181	0.49585123021520294	1	2
JAK2	tumor-associated macrophages/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
JAK2	basic-leucine zipper transcription factors/analysis	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
JAK2	drug resistance neoplasm	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
JAK2	GGT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
JAK2	SMAD3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
JAK2	STAT3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
JAK2	TGFB1	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
raw 264.7 cells	dose-response relationship drug	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
raw 264.7 cells	microglia/drug effects	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
raw 264.7 cells	lipopolysaccharides/toxicity	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
raw 264.7 cells	inflammation mediators/antagonists &amp; inhibitors	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
raw 264.7 cells	nf-e2-related factor 2/biosynthesis	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
raw 264.7 cells	gene expression	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
raw 264.7 cells	NFE2L2	0.00010015305117716533	0.0002704132381783464	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	microglia/drug effects	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	methotrexate/pharmacology	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	vitamin e/pharmacology	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	cystine/antagonists &amp; inhibitors	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	lipopolysaccharides/toxicity	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	inflammation mediators/antagonists &amp; inhibitors	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	oxidative stress	0.004006594837651867	0.007247331657780852	0.11931818181818181	0.49585123021520294	1	2
dose-response relationship drug	tetrahydrofolate dehydrogenase/genetics	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	folic acid antagonists/pharmacology	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	nf-e2-related factor 2/biosynthesis	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
dose-response relationship drug	gene expression	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
ferric compounds/chemistry	gels/chemistry	3.1080856240928156e-06	1.3199272715303257e-05	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	benzylidene compounds/chemistry	0.00020855109647122116	0.0005470284107975078	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	ascorbic acid/pharmacology	7.252766005549915e-07	3.273756189314939e-06	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	metal-organic frameworks/chemistry	0.00020855109647122116	0.0005470284107975078	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	macrophages/cytology	0.003519437482903842	0.0063818265632692595	0.17613636363636365	0.49585123021520294	1	2
ferric compounds/chemistry	t-lymphocytes cytotoxic/metabolism	7.252766005549915e-07	3.273756189314939e-06	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	urinary bladder neoplasms/pathology	3.1080856240928156e-06	1.3199272715303257e-05	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	exosomes/metabolism	0.00020855109647122116	0.0005470284107975078	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	interferon-gamma/metabolism	0.00020855109647122116	0.0005470284107975078	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	immunogenic cell death/drug effects	0.00020855109647122116	0.0005470284107975078	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	aniline compounds/chemistry	0.00020855109647122116	0.0005470284107975078	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	neoplasms/diagnostic imaging	7.252766005549915e-07	3.273756189314939e-06	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	phenol/chemistry	0.00020855109647122116	0.0005470284107975078	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	gold/chemistry	3.1080856240928156e-06	1.3199272715303257e-05	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	adjuvants immunologic/chemistry	3.1080856240928156e-06	1.3199272715303257e-05	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	calreticulin/metabolism	7.252766005549915e-07	3.273756189314939e-06	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	b7-h1 antigen/metabolism	0.00020855109647122116	0.0005470284107975078	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	programmed cell death 1 receptor/metabolism	0.00020855109647122116	0.0005470284107975078	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	dextrans/chemistry	3.1080856240928156e-06	1.3199272715303257e-05	0.09090909090909091	0.49585123021520294	1	2
ferric compounds/chemistry	CALR	7.252766005549915e-07	3.273756189314939e-06	0.09090909090909091	0.49585123021520294	1	2
PDCD1	cd8-positive t-lymphocytes/cytology	3.120825768010427e-05	9.333933165909233e-05	0.0007331378299120234	0.05284149450553068	3	2
SMAD3	tumor-associated macrophages/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
SMAD3	basic-leucine zipper transcription factors/analysis	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
SMAD3	drug resistance neoplasm	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
SMAD3	STAT3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
SMAD3	TGFB1	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
SMAD3	GGT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
microglia/drug effects	lipopolysaccharides/toxicity	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
microglia/drug effects	inflammation mediators/antagonists &amp; inhibitors	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
microglia/drug effects	nf-e2-related factor 2/biosynthesis	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
microglia/drug effects	gene expression	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
microglia/drug effects	NFE2L2	0.00010015305117716533	0.0002704132381783464	0.06060606060606061	0.49585123021520294	1	2
STAT3	tumor-associated macrophages/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
STAT3	basic-leucine zipper transcription factors/analysis	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
STAT3	drug resistance neoplasm	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
STAT3	TGFB1	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
STAT3	GGT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
methotrexate/pharmacology	vitamin e/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
methotrexate/pharmacology	jurkat cells	0.0005236625778490822	0.0011135397157585613	0.06060606060606061	0.49585123021520294	1	2
methotrexate/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
methotrexate/pharmacology	cystine/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
methotrexate/pharmacology	oxidative stress	0.00017732562798067342	0.0004688852858464707	0.06060606060606061	0.49585123021520294	1	2
methotrexate/pharmacology	tetrahydrofolate dehydrogenase/genetics	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
methotrexate/pharmacology	folic acid antagonists/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
methotrexate/pharmacology	gene expression regulation neoplastic	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
hmgb1 protein/metabolism	endothelial cells/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	hemodynamics/drug effects	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	inflammation/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	monocrotaline/toxicity	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	heart ventricles/diagnostic imaging	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	nlr family pyrin domain-containing 3 protein/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
hmgb1 protein/metabolism	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	FTH1	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	HMGB1	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	NLRP3	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hmgb1 protein/metabolism	NOX4	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	hemodynamics/drug effects	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	inflammation/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	monocrotaline/toxicity	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	heart ventricles/diagnostic imaging	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	nlr family pyrin domain-containing 3 protein/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
endothelial cells/metabolism	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	FTH1	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	HMGB1	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	NLRP3	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
endothelial cells/metabolism	NOX4	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
TGFB1	tumor-associated macrophages/drug effects	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
TGFB1	basic-leucine zipper transcription factors/analysis	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
TGFB1	drug resistance neoplasm	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
TGFB1	benzylamines	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
TGFB1	leukemia myeloid acute/drug therapy	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
TGFB1	receptors cxcr4/antagonists &amp; inhibitors	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
TGFB1	cyclams	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
TGFB1	transforming growth factor beta/antagonists &amp; inhibitors	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
TGFB1	cytarabine/pharmacology	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
TGFB1	GGT1	8.807558886381184e-05	0.0002454606610096574	0.06060606060606061	0.49585123021520294	1	2
TGFB1	chemokine cxcl12/metabolism	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
TGFB1	antibodies neutralizing/metabolism	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
TGFB1	CXCL12	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
TGFB1	CXCR4	0.0006570549362086009	0.0013675478622785803	0.06060606060606061	0.49585123021520294	1	2
glutathione peroxidase/metabolism	jurkat cells	3.175568914837168e-05	9.440100319561399e-05	0.06060606060606061	0.49585123021520294	1	2
glutathione peroxidase/metabolism	cell cycle/drug effects	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
glutathione peroxidase/metabolism	autophagy-related proteins/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
glutathione peroxidase/metabolism	glutathione/metabolism	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
glutathione peroxidase/metabolism	flavonolignans/pharmacology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
glutathione peroxidase/metabolism	ATG5	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
glutathione peroxidase/metabolism	precursor cell lymphoblastic leukemia-lymphoma/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
glutathione peroxidase/metabolism	autophagy/drug effects	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
jurkat cells	precursor cell lymphoblastic leukemia-lymphoma/metabolism	3.175568914837168e-05	9.440100319561399e-05	0.06060606060606061	0.49585123021520294	1	2
jurkat cells	autophagy/drug effects	0.0038949757905539784	0.007058444428325344	0.11931818181818181	0.49585123021520294	1	2
jurkat cells	vitamin e/pharmacology	0.0005236625778490822	0.0011135397157585613	0.06060606060606061	0.49585123021520294	1	2
jurkat cells	phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	0.0005236625778490822	0.0011135397157585613	0.06060606060606061	0.49585123021520294	1	2
jurkat cells	cystine/antagonists &amp; inhibitors	0.0005236625778490822	0.0011135397157585613	0.06060606060606061	0.49585123021520294	1	2
jurkat cells	oxidative stress	0.004748209340335929	0.008443492500669872	0.11931818181818181	0.49585123021520294	1	2
jurkat cells	cell cycle/drug effects	3.175568914837168e-05	9.440100319561399e-05	0.06060606060606061	0.49585123021520294	1	2
jurkat cells	autophagy-related proteins/genetics	3.175568914837168e-05	9.440100319561399e-05	0.06060606060606061	0.49585123021520294	1	2
jurkat cells	tetrahydrofolate dehydrogenase/genetics	0.0005236625778490822	0.0011135397157585613	0.06060606060606061	0.49585123021520294	1	2
jurkat cells	folic acid antagonists/pharmacology	0.0005236625778490822	0.0011135397157585613	0.06060606060606061	0.49585123021520294	1	2
jurkat cells	flavonolignans/pharmacology	3.175568914837168e-05	9.440100319561399e-05	0.06060606060606061	0.49585123021520294	1	2
jurkat cells	ATG5	3.175568914837168e-05	9.440100319561399e-05	0.06060606060606061	0.49585123021520294	1	2
iron/metabolism	malaria/genetics	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	coenzyme a ligases/metabolism	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	neoplasm metastasis/drug therapy	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	transferrin/metabolism	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	ferritins/blood	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	genetic variation	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	lymph/metabolism	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	5.061393608563058e-06	1.8783961399749158e-05	0.011363636363636364	0.18259996156874114	2	2
iron/metabolism	iron chelating agents/pharmacology	0.00031680908782472095	0.0007750366961497537	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	liver x receptors/agonists	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	listeriosis/etiology	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	hemeproteins/toxicity	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	glutathione/metabolism	0.0004298778481803822	0.0009950079515128947	0.032624633431085036	0.18259996156874114	2	2
iron/metabolism	oleic acid/metabolism	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	tumor suppressor protein p53/genetics	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	cell survival	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	host-pathogen interactions	0.00031680908782472095	0.0007750366961497537	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	tuberculosis/metabolism	0.00031680908782472095	0.0007750366961497537	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	melanoma/blood	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	ACSL3	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
iron/metabolism	TF	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
tumor microenvironment	pancreatitis/genetics	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	cytokines/metabolism	0.0017748607761071122	0.003489255353429012	0.11931818181818181	0.49585123021520294	1	2
tumor microenvironment	phospholipid hydroperoxide glutathione peroxidase/genetics	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	proto-oncogene proteins p21(ras)/metabolism	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	cell transformation neoplastic/genetics	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	spiro compounds/pharmacology	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	CD36	4.3519227207355904e-05	0.0001275668183976578	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	KDM8	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	STING1	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	biomarkers tumor	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	macrophages	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	dna	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	diet	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	membrane proteins/genetics	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	pancreas/metabolism	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	quinoxalines/pharmacology	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	antibodies monoclonal humanized/pharmacology	4.3519227207355904e-05	0.0001275668183976578	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	multiple myeloma/drug therapy	0.005566454437330726	0.009630849740778557	0.11931818181818181	0.49585123021520294	1	2
tumor microenvironment	cd36 antigens/antagonists &amp; inhibitors	4.3519227207355904e-05	0.0001275668183976578	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	fatty acids/metabolism	4.3519227207355904e-05	0.0001275668183976578	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment	carcinoma pancreatic ductal/metabolism	0.0009481193198297433	0.001944470493560233	0.06060606060606061	0.49585123021520294	1	2
phenols/chemistry	antineoplastic agents/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
phenols/chemistry	gene expression regulation neoplastic/drug effects	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
phenols/chemistry	multiple myeloma/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
phenols/chemistry	aldehydes/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
phenols/chemistry	proto-oncogene proteins c-akt/metabolism	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
phenols/chemistry	chemokine ccl3/genetics	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
phenols/chemistry	cyclopentane monoterpenes	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
phenols/chemistry	AKT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
phenols/chemistry	CCL3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
phenols/chemistry	MAPK3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	pancreatitis/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	phospholipid hydroperoxide glutathione peroxidase/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	proto-oncogene proteins p21(ras)/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	cell transformation neoplastic/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	macrophages	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	dna	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	diet	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	membrane proteins/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	KDM8	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
biomarkers tumor	STING1	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
vitamin e/pharmacology	phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
vitamin e/pharmacology	cystine/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
vitamin e/pharmacology	oxidative stress	0.00017732562798067342	0.0004688852858464707	0.06060606060606061	0.49585123021520294	1	2
vitamin e/pharmacology	tetrahydrofolate dehydrogenase/genetics	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
vitamin e/pharmacology	folic acid antagonists/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
vitamin e/pharmacology	gene expression regulation neoplastic	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
collagen type i/metabolism	cell line	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
collagen type i/metabolism	hepatic stellate cells/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
collagen type i/metabolism	liver cirrhosis/drug therapy	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
collagen type i/metabolism	actins/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
collagen type i/metabolism	amino acid transport system y+/metabolism	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
collagen type i/metabolism	hypoxia-inducible factor 1 alpha subunit/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
collagen type i/metabolism	FN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
collagen type i/metabolism	HIF1A	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
collagen type i/metabolism	MMRN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
collagen type i/metabolism	sorafenib/pharmacology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
collagen type i/metabolism	hepatocytes/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cell line	sorafenib/pharmacology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cell line	hepatocytes/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cell line	hepatic stellate cells/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cell line	liver cirrhosis/drug therapy	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cell line	actins/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cell line	amino acid transport system y+/metabolism	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
cell line	hypoxia-inducible factor 1 alpha subunit/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cell line	FN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cell line	HIF1A	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cell line	MMRN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	cell transformation neoplastic/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	proto-oncogene proteins p21(ras)/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	phospholipid hydroperoxide glutathione peroxidase/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	macrophages	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	dna	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	diet	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	membrane proteins/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	KDM8	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreatitis/genetics	STING1	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
protein kinase inhibitors/chemistry	mitochondria/drug effects	0.0005309212813094932	0.0011232935520444562	0.06060606060606061	0.49585123021520294	1	2
protein kinase inhibitors/chemistry	energy metabolism/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
protein kinase inhibitors/chemistry	antineoplastic agents/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
protein kinase inhibitors/chemistry	pyruvate dehydrogenase acetyl-transferring kinase/antagonists &amp; inhibitors	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
protein kinase inhibitors/chemistry	macrophages/cytology	4.136049573721934e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
protein kinase inhibitors/chemistry	dichloroacetic acid/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
protein kinase inhibitors/chemistry	neoplasms/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
protein kinase inhibitors/chemistry	drug synergism	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
protein kinase inhibitors/chemistry	biological products/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
protein kinase inhibitors/chemistry	saponins/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
apoptosis/drug effects	antineoplastic agents/chemistry	1.3184154911360935e-05	4.559455687912483e-05	0.003665689149560118	0.05284149450553068	3	2
apoptosis/drug effects	radiation-protective agents/pharmacology	0.0012907246071859335	0.0025876038957412823	0.1818181818181818	0.49585123021520294	1	2
apoptosis/drug effects	drug interactions	0.0012907246071859335	0.0025876038957412823	0.1818181818181818	0.49585123021520294	1	2
apoptosis/drug effects	necroptosis/drug effects	0.0012907246071859335	0.0025876038957412823	0.1818181818181818	0.49585123021520294	1	2
apoptosis/drug effects	ileum/drug effects	0.0012907246071859335	0.0025876038957412823	0.1818181818181818	0.49585123021520294	1	2
apoptosis/drug effects	bone marrow/drug effects	5.405700270744163e-07	2.4588834461823914e-06	0.0003665689149560117	0.012528984725409973	4	2
apoptosis/drug effects	small molecule libraries/pharmacology	0.0012907246071859335	0.0025876038957412823	0.18181818181818182	0.49585123021520294	1	2
apoptosis/drug effects	leukemia lymphocytic chronic b-cell/immunology	0.0012907246071859335	0.0025876038957412823	0.18181818181818182	0.49585123021520294	1	2
apoptosis/drug effects	heterografts/drug effects	0.0012907246071859335	0.0025876038957412823	0.18181818181818182	0.49585123021520294	1	2
apoptosis/drug effects	vidarabine/analogs &amp; derivatives	0.0012907246071859335	0.0025876038957412823	0.18181818181818182	0.49585123021520294	1	2
apoptosis/drug effects	trisaccharides/chemistry	0.0012907246071859335	0.0025876038957412823	0.18181818181818182	0.49585123021520294	1	2
apoptosis/drug effects	tissue distribution	0.0012907246071859335	0.0025876038957412823	0.18181818181818182	0.49585123021520294	1	2
tumor-associated macrophages/drug effects	drug resistance neoplasm	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
tumor-associated macrophages/drug effects	basic-leucine zipper transcription factors/analysis	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
tumor-associated macrophages/drug effects	GGT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	KDM8	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	STING1	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	phospholipid hydroperoxide glutathione peroxidase/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	macrophages	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	dna	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	diet	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	membrane proteins/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	cell transformation neoplastic/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins p21(ras)/metabolism	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	phospholipid hydroperoxide glutathione peroxidase/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	cell transformation neoplastic/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	dna	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	macrophages	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	diet	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	membrane proteins/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
KDM8	STING1	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	FTH1	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	HMGB1	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	NLRP3	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	NOX4	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	inflammation/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	monocrotaline/toxicity	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	heart ventricles/diagnostic imaging	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	nlr family pyrin domain-containing 3 protein/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
hemodynamics/drug effects	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hemodynamics/drug effects	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
malaria/genetics	genetic variation	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
malaria/genetics	transferrin/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
malaria/genetics	ferritins/blood	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
malaria/genetics	macrophages/drug effects	0.0049695547136417995	0.00875772426481905	0.12121212121212122	0.49585123021520294	1	2
malaria/genetics	liver x receptors/agonists	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
malaria/genetics	listeriosis/etiology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
malaria/genetics	hemeproteins/toxicity	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
malaria/genetics	tumor suppressor protein p53/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
malaria/genetics	TF	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
malaria/genetics	TP53	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
cell transformation neoplastic/genetics	phospholipid hydroperoxide glutathione peroxidase/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cell transformation neoplastic/genetics	macrophages	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cell transformation neoplastic/genetics	dna	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cell transformation neoplastic/genetics	diet	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cell transformation neoplastic/genetics	membrane proteins/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cell transformation neoplastic/genetics	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cell transformation neoplastic/genetics	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cell transformation neoplastic/genetics	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cell transformation neoplastic/genetics	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cell transformation neoplastic/genetics	STING1	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
aldehydes/chemistry	antineoplastic agents/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
aldehydes/chemistry	gene expression regulation neoplastic/drug effects	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
aldehydes/chemistry	multiple myeloma/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
aldehydes/chemistry	proto-oncogene proteins c-akt/metabolism	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
aldehydes/chemistry	chemokine ccl3/genetics	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
aldehydes/chemistry	cyclopentane monoterpenes	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
aldehydes/chemistry	AKT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
aldehydes/chemistry	CCL3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
aldehydes/chemistry	MAPK3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins c-akt/metabolism	antineoplastic agents/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
proto-oncogene proteins c-akt/metabolism	gene expression regulation neoplastic/drug effects	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
proto-oncogene proteins c-akt/metabolism	multiple myeloma/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
proto-oncogene proteins c-akt/metabolism	chemokine ccl3/genetics	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins c-akt/metabolism	cyclopentane monoterpenes	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins c-akt/metabolism	AKT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins c-akt/metabolism	CCL3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
proto-oncogene proteins c-akt/metabolism	MAPK3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
macrophages	phospholipid hydroperoxide glutathione peroxidase/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
macrophages	dna	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
macrophages	diet	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
macrophages	membrane proteins/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
macrophages	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
macrophages	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
macrophages	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
macrophages	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
macrophages	STING1	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
dna	phospholipid hydroperoxide glutathione peroxidase/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
dna	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
dna	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
dna	STING1	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
dna	diet	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
dna	membrane proteins/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
dna	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
dna	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
chemokine ccl3/genetics	antineoplastic agents/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
chemokine ccl3/genetics	gene expression regulation neoplastic/drug effects	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
chemokine ccl3/genetics	multiple myeloma/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
chemokine ccl3/genetics	cyclopentane monoterpenes	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
chemokine ccl3/genetics	AKT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
chemokine ccl3/genetics	CCL3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
chemokine ccl3/genetics	MAPK3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	cystine/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	oxidative stress	0.00017732562798067342	0.0004688852858464707	0.06060606060606061	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	tetrahydrofolate dehydrogenase/genetics	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	folic acid antagonists/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/antagonists &amp; inhibitors	gene expression regulation neoplastic	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
cytokines/metabolism	radiation-protective agents/pharmacology	5.776805700463683e-10	6.1822324278053165e-09	0.06060606060606061	0.49585123021520294	1	2
cytokines/metabolism	drug interactions	5.776805700463683e-10	6.1822324278053165e-09	0.06060606060606061	0.49585123021520294	1	2
cytokines/metabolism	ileum/drug effects	5.776805700463683e-10	6.1822324278053165e-09	0.06060606060606061	0.49585123021520294	1	2
cytokines/metabolism	necroptosis/drug effects	5.776805700463683e-10	6.1822324278053165e-09	0.06060606060606061	0.49585123021520294	1	2
cytokines/metabolism	antibodies monoclonal humanized/pharmacology	4.6926949615055946e-07	2.1378639739490657e-06	0.06060606060606061	0.49585123021520294	1	2
cytokines/metabolism	multiple myeloma/drug therapy	0.0005759911099987303	0.001217774307993005	0.11931818181818181	0.49585123021520294	1	2
cytokines/metabolism	cd36 antigens/antagonists &amp; inhibitors	4.6926949615055946e-07	2.1378639739490657e-06	0.06060606060606061	0.49585123021520294	1	2
cytokines/metabolism	fatty acids/metabolism	4.6926949615055946e-07	2.1378639739490657e-06	0.06060606060606061	0.49585123021520294	1	2
cytokines/metabolism	small molecule libraries/pharmacology	5.776805700463683e-10	6.1822324278053165e-09	0.06060606060606061	0.49585123021520294	1	2
cytokines/metabolism	CD36	4.6926949615055946e-07	2.1378639739490657e-06	0.06060606060606061	0.49585123021520294	1	2
hepatic stellate cells/drug effects	sorafenib/pharmacology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hepatic stellate cells/drug effects	hepatocytes/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hepatic stellate cells/drug effects	liver cirrhosis/drug therapy	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hepatic stellate cells/drug effects	actins/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hepatic stellate cells/drug effects	amino acid transport system y+/metabolism	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
hepatic stellate cells/drug effects	hypoxia-inducible factor 1 alpha subunit/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hepatic stellate cells/drug effects	FN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hepatic stellate cells/drug effects	HIF1A	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hepatic stellate cells/drug effects	MMRN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cyclopentane monoterpenes	antineoplastic agents/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
cyclopentane monoterpenes	gene expression regulation neoplastic/drug effects	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
cyclopentane monoterpenes	multiple myeloma/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
cyclopentane monoterpenes	AKT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
cyclopentane monoterpenes	CCL3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
cyclopentane monoterpenes	MAPK3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	immunologic memory	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	aniline compounds/pharmacology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	t-lymphocytes cytotoxic/drug effects	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	immune checkpoint inhibitors/pharmacology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	tumor escape/drug effects	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	tumor microenvironment/drug effects	0.00569040041684965	0.009839511414094313	0.028409090909090908	0.18259996156874114	2	2
drug resistance neoplasm/drug effects	b7-h1 antigen/antagonists &amp; inhibitors	0.004842334459021824	0.008584933923434476	0.11931818181818181	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	benzylidene compounds/pharmacology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	hyaluronic acid/chemistry	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	skin neoplasms/drug therapy	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	exosomes/drug effects	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	cell line tumor/transplantation	0.005704538562607997	0.009846602340032455	0.11931818181818181	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	mutant proteins/metabolism	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	multiple myeloma/genetics	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	osteoprotegerin/genetics	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	tnf-related apoptosis-inducing ligand/genetics	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	mutation	0.0022077059921027375	0.004096459659343585	0.11931818181818181	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	recombinant proteins/metabolism	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
drug resistance neoplasm/drug effects	TNFRSF11B	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
immunologic memory	aniline compounds/pharmacology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunologic memory	t-lymphocytes cytotoxic/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunologic memory	immune checkpoint inhibitors/pharmacology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunologic memory	tumor escape/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunologic memory	b7-h1 antigen/antagonists &amp; inhibitors	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
immunologic memory	benzylidene compounds/pharmacology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunologic memory	hyaluronic acid/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunologic memory	skin neoplasms/drug therapy	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunologic memory	exosomes/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunologic memory	cell line tumor/transplantation	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
immunologic memory	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
STING1	phospholipid hydroperoxide glutathione peroxidase/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
STING1	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
STING1	diet	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
STING1	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
STING1	membrane proteins/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
STING1	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
STING1	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cystine/antagonists &amp; inhibitors	oxidative stress	0.00017732562798067342	0.0004688852858464707	0.06060606060606061	0.49585123021520294	1	2
cystine/antagonists &amp; inhibitors	tetrahydrofolate dehydrogenase/genetics	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
cystine/antagonists &amp; inhibitors	folic acid antagonists/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
cystine/antagonists &amp; inhibitors	gene expression regulation neoplastic	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
aniline compounds/pharmacology	t-lymphocytes cytotoxic/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
aniline compounds/pharmacology	immune checkpoint inhibitors/pharmacology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
aniline compounds/pharmacology	tumor escape/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
aniline compounds/pharmacology	b7-h1 antigen/antagonists &amp; inhibitors	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
aniline compounds/pharmacology	benzylidene compounds/pharmacology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
aniline compounds/pharmacology	hyaluronic acid/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
aniline compounds/pharmacology	skin neoplasms/drug therapy	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
aniline compounds/pharmacology	exosomes/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
aniline compounds/pharmacology	cell line tumor/transplantation	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
aniline compounds/pharmacology	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
AKT1	antineoplastic agents/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
AKT1	gene expression regulation neoplastic/drug effects	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
AKT1	multiple myeloma/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
AKT1	CCL3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
AKT1	MAPK3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
coenzyme a ligases/metabolism	neoplasm metastasis/drug therapy	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
coenzyme a ligases/metabolism	lymph/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
coenzyme a ligases/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	8.925257763969796e-07	3.95587855412095e-06	0.06060606060606061	0.49585123021520294	1	2
coenzyme a ligases/metabolism	glutathione/metabolism	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
coenzyme a ligases/metabolism	oleic acid/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
coenzyme a ligases/metabolism	cell survival	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
coenzyme a ligases/metabolism	oxidative stress/drug effects	0.00024787161677153335	0.0006234924514176263	0.06060606060606061	0.49585123021520294	1	2
coenzyme a ligases/metabolism	melanoma/blood	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
coenzyme a ligases/metabolism	ACSL3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
CCL3	antineoplastic agents/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
CCL3	gene expression regulation neoplastic/drug effects	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
CCL3	multiple myeloma/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
CCL3	MAPK3	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis/drug therapy	lymph/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis/drug therapy	phospholipid hydroperoxide glutathione peroxidase/metabolism	8.925257763969796e-07	3.95587855412095e-06	0.06060606060606061	0.49585123021520294	1	2
neoplasm metastasis/drug therapy	glutathione/metabolism	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
neoplasm metastasis/drug therapy	oleic acid/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis/drug therapy	cell survival	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis/drug therapy	oxidative stress/drug effects	0.00024787161677153335	0.0006234924514176263	0.06060606060606061	0.49585123021520294	1	2
neoplasm metastasis/drug therapy	melanoma/blood	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis/drug therapy	ACSL3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
MAPK3	antineoplastic agents/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
MAPK3	gene expression regulation neoplastic/drug effects	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
MAPK3	multiple myeloma/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
FTH1	inflammation/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	monocrotaline/toxicity	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	nlr family pyrin domain-containing 3 protein/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	heart ventricles/diagnostic imaging	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
FTH1	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	HMGB1	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	NLRP3	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
FTH1	NOX4	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
t-lymphocytes cytotoxic/drug effects	immune checkpoint inhibitors/pharmacology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
t-lymphocytes cytotoxic/drug effects	tumor escape/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
t-lymphocytes cytotoxic/drug effects	b7-h1 antigen/antagonists &amp; inhibitors	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/drug effects	benzylidene compounds/pharmacology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
t-lymphocytes cytotoxic/drug effects	hyaluronic acid/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
t-lymphocytes cytotoxic/drug effects	skin neoplasms/drug therapy	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
t-lymphocytes cytotoxic/drug effects	exosomes/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
t-lymphocytes cytotoxic/drug effects	cell line tumor/transplantation	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/drug effects	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase	iron/blood	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase	spleen/pathology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase	glutathione	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase	liver/pathology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase	malondialdehyde/blood	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase	kidney	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
transferrin/metabolism	genetic variation	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
transferrin/metabolism	ferritins/blood	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
transferrin/metabolism	macrophages/drug effects	0.0049695547136417995	0.00875772426481905	0.12121212121212122	0.49585123021520294	1	2
transferrin/metabolism	liver x receptors/agonists	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
transferrin/metabolism	listeriosis/etiology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
transferrin/metabolism	hemeproteins/toxicity	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
transferrin/metabolism	tumor suppressor protein p53/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
transferrin/metabolism	TF	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
transferrin/metabolism	TP53	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
GPX4	glutathione peroxidase/therapeutic use	0.004442423049917488	0.007909286773083586	0.3333333333333333	0.49585123021520294	1	2
GPX4	b-lymphocytes/metabolism	0.004442423049917488	0.007909286773083586	0.3333333333333333	0.49585123021520294	1	2
GPX4	glutathione/metabolism	0.004920871227248491	0.008718918736780438	0.030241935483870972	0.05284149450553068	3	2
GPX4	cytoskeletal proteins/metabolism	0.004442423049917488	0.007909286773083586	0.3333333333333333	0.49585123021520294	1	2
GPX4	BDKRB2	0.004442423049917488	0.007909286773083586	0.3333333333333333	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	diet	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	membrane proteins/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/genetics	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
liver cirrhosis/drug therapy	sorafenib/pharmacology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
liver cirrhosis/drug therapy	hepatocytes/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
liver cirrhosis/drug therapy	actins/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
liver cirrhosis/drug therapy	amino acid transport system y+/metabolism	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
liver cirrhosis/drug therapy	hypoxia-inducible factor 1 alpha subunit/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
liver cirrhosis/drug therapy	FN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
liver cirrhosis/drug therapy	HIF1A	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
liver cirrhosis/drug therapy	MMRN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
HMGB1	inflammation/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	monocrotaline/toxicity	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	nlr family pyrin domain-containing 3 protein/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	heart ventricles/diagnostic imaging	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
HMGB1	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	NLRP3	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
HMGB1	NOX4	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
inflammation/metabolism	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	NLRP3	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	NOX4	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	monocrotaline/toxicity	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	heart ventricles/diagnostic imaging	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammation/metabolism	nlr family pyrin domain-containing 3 protein/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
immune checkpoint inhibitors/pharmacology	tumor escape/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immune checkpoint inhibitors/pharmacology	b7-h1 antigen/antagonists &amp; inhibitors	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
immune checkpoint inhibitors/pharmacology	benzylidene compounds/pharmacology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immune checkpoint inhibitors/pharmacology	hyaluronic acid/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immune checkpoint inhibitors/pharmacology	skin neoplasms/drug therapy	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immune checkpoint inhibitors/pharmacology	exosomes/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immune checkpoint inhibitors/pharmacology	cell line tumor/transplantation	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
immune checkpoint inhibitors/pharmacology	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
diet	membrane proteins/genetics	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
diet	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
diet	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
diet	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
diet	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
NLRP3	monocrotaline/toxicity	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NLRP3	nlr family pyrin domain-containing 3 protein/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NLRP3	heart ventricles/diagnostic imaging	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NLRP3	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NLRP3	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NLRP3	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
NLRP3	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NLRP3	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NLRP3	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NLRP3	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NLRP3	NOX4	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
monocrotaline/toxicity	heart ventricles/diagnostic imaging	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
monocrotaline/toxicity	nlr family pyrin domain-containing 3 protein/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
monocrotaline/toxicity	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
monocrotaline/toxicity	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
monocrotaline/toxicity	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
monocrotaline/toxicity	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
monocrotaline/toxicity	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
monocrotaline/toxicity	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
monocrotaline/toxicity	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
monocrotaline/toxicity	NOX4	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
lipopolysaccharides/toxicity	inflammation mediators/antagonists &amp; inhibitors	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
lipopolysaccharides/toxicity	nf-e2-related factor 2/biosynthesis	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
lipopolysaccharides/toxicity	gene expression	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
lipopolysaccharides/toxicity	NFE2L2	0.00010015305117716533	0.0002704132381783464	0.06060606060606061	0.49585123021520294	1	2
gels/chemistry	macrophages/cytology	2.708995805456027e-08	1.4601785083254738e-07	0.06060606060606061	0.49585123021520294	1	2
gels/chemistry	urinary bladder neoplasms/pathology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
gels/chemistry	gold/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
gels/chemistry	adjuvants immunologic/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
gels/chemistry	dextrans/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
NOX4	nlr family pyrin domain-containing 3 protein/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NOX4	heart ventricles/diagnostic imaging	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NOX4	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NOX4	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NOX4	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
NOX4	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NOX4	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NOX4	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
NOX4	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
mitochondria/drug effects	pyruvate dehydrogenase acetyl-transferring kinase/antagonists &amp; inhibitors	0.0005309212813094932	0.0011232935520444562	0.06060606060606061	0.49585123021520294	1	2
mitochondria/drug effects	dichloroacetic acid/chemistry	0.0005309212813094932	0.0011232935520444562	0.06060606060606061	0.49585123021520294	1	2
mitochondria/drug effects	drug synergism	0.0005309212813094932	0.0011232935520444562	0.06060606060606061	0.49585123021520294	1	2
mitochondria/drug effects	biological products/chemistry	0.0005309212813094932	0.0011232935520444562	0.06060606060606061	0.49585123021520294	1	2
mitochondria/drug effects	saponins/chemistry	0.0005309212813094932	0.0011232935520444562	0.06060606060606061	0.49585123021520294	1	2
mitochondria/drug effects	energy metabolism/drug effects	0.0005309212813094932	0.0011232935520444562	0.06060606060606061	0.49585123021520294	1	2
inflammation mediators/antagonists &amp; inhibitors	nf-e2-related factor 2/biosynthesis	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
inflammation mediators/antagonists &amp; inhibitors	gene expression	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
inflammation mediators/antagonists &amp; inhibitors	NFE2L2	0.00010015305117716533	0.0002704132381783464	0.06060606060606061	0.49585123021520294	1	2
sulfasalazine/administration &amp; dosage	lipid metabolism/drug effects	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
sulfasalazine/administration &amp; dosage	cd8-positive t-lymphocytes/immunology	0.0019835623240943567	0.003832976966388504	0.09090909090909091	0.49585123021520294	1	2
sulfasalazine/administration &amp; dosage	gene expression regulation neoplastic/drug effects	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
sulfasalazine/administration &amp; dosage	amino acid transport system y+/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
sulfasalazine/administration &amp; dosage	antineoplastic agents immunological/administration &amp; dosage	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
sulfasalazine/administration &amp; dosage	ATM	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
sulfasalazine/administration &amp; dosage	SLC7A11	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
sulfasalazine/administration &amp; dosage	SLC9A1	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
ferritins/blood	genetic variation	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
ferritins/blood	macrophages/drug effects	0.0049695547136417995	0.00875772426481905	0.12121212121212122	0.49585123021520294	1	2
ferritins/blood	liver x receptors/agonists	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
ferritins/blood	listeriosis/etiology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
ferritins/blood	hemeproteins/toxicity	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
ferritins/blood	tumor suppressor protein p53/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
ferritins/blood	TF	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
ferritins/blood	TP53	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
cyclohexylamines/pharmacology	neutrophil infiltration	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
cyclohexylamines/pharmacology	myocardium/immunology	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
cyclohexylamines/pharmacology	toll-like receptor 4/genetics	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
cyclohexylamines/pharmacology	phenylenediamines/pharmacology	2.330015635065852e-05	6.975825039673247e-05	0.001893939393939394	0.18259996156874114	2	2
cyclohexylamines/pharmacology	inflammation/drug therapy	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
cyclohexylamines/pharmacology	adaptor proteins vesicular transport/genetics	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
cyclohexylamines/pharmacology	ventricular function left/drug effects	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
cyclohexylamines/pharmacology	neutrophils/immunology	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
cyclohexylamines/pharmacology	myocardial reperfusion injury/drug therapy	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
cyclohexylamines/pharmacology	TICAM1	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
cyclohexylamines/pharmacology	TLR4	2.330015635065852e-05	6.975825039673247e-05	0.001893939393939394	0.18259996156874114	2	2
cyclohexylamines/pharmacology	TRIM69	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
genetic variation	macrophages/drug effects	0.0049695547136417995	0.00875772426481905	0.12121212121212122	0.49585123021520294	1	2
genetic variation	liver x receptors/agonists	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
genetic variation	listeriosis/etiology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
genetic variation	hemeproteins/toxicity	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
genetic variation	tumor suppressor protein p53/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
genetic variation	TF	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
genetic variation	TP53	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
actins/metabolism	sorafenib/pharmacology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
actins/metabolism	hepatocytes/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
actins/metabolism	amino acid transport system y+/metabolism	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
actins/metabolism	hypoxia-inducible factor 1 alpha subunit/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
actins/metabolism	FN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
actins/metabolism	HIF1A	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
actins/metabolism	MMRN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
lymph/metabolism	phospholipid hydroperoxide glutathione peroxidase/metabolism	8.925257763969796e-07	3.95587855412095e-06	0.06060606060606061	0.49585123021520294	1	2
lymph/metabolism	glutathione/metabolism	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
lymph/metabolism	oleic acid/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
lymph/metabolism	cell survival	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
lymph/metabolism	oxidative stress/drug effects	0.00024787161677153335	0.0006234924514176263	0.06060606060606061	0.49585123021520294	1	2
lymph/metabolism	melanoma/blood	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
lymph/metabolism	ACSL3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
TLR4	neutrophil infiltration	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
TLR4	myocardium/immunology	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
TLR4	toll-like receptor 4/genetics	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
TLR4	inflammation/drug therapy	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
TLR4	adaptor proteins vesicular transport/genetics	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
TLR4	ventricular function left/drug effects	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
TLR4	neutrophils/immunology	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
TLR4	phenylenediamines/pharmacology	2.330015635065852e-05	6.975825039673247e-05	0.001893939393939394	0.18259996156874114	2	2
TLR4	myocardial reperfusion injury/drug therapy	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
TLR4	TICAM1	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
TLR4	TRIM69	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
cell cycle/drug effects	precursor cell lymphoblastic leukemia-lymphoma/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
cell cycle/drug effects	autophagy/drug effects	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
cell cycle/drug effects	autophagy-related proteins/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
cell cycle/drug effects	glutathione/metabolism	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
cell cycle/drug effects	flavonolignans/pharmacology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
cell cycle/drug effects	ATG5	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
oxidative stress	ascorbic acid/pharmacology	3.1870832750691136e-08	1.7022842247782942e-07	0.06060606060606061	0.49585123021520294	1	2
oxidative stress	t-lymphocytes cytotoxic/metabolism	3.1870832750691136e-08	1.7022842247782942e-07	0.06060606060606061	0.49585123021520294	1	2
oxidative stress	tetrahydrofolate dehydrogenase/genetics	0.00017732562798067342	0.0004688852858464707	0.06060606060606061	0.49585123021520294	1	2
oxidative stress	neoplasms/diagnostic imaging	3.1870832750691136e-08	1.7022842247782942e-07	0.06060606060606061	0.49585123021520294	1	2
oxidative stress	folic acid antagonists/pharmacology	0.00017732562798067342	0.0004688852858464707	0.06060606060606061	0.49585123021520294	1	2
oxidative stress	gene expression regulation neoplastic	0.004006594837651867	0.007247331657780852	0.11931818181818181	0.49585123021520294	1	2
oxidative stress	calreticulin/metabolism	3.1870832750691136e-08	1.7022842247782942e-07	0.06060606060606061	0.49585123021520294	1	2
oxidative stress	CALR	3.1870832750691136e-08	1.7022842247782942e-07	0.06060606060606061	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/metabolism	cells cultured	0.0027703160254957115	0.005082942682689451	0.11931818181818181	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/metabolism	iron chelating agents/pharmacology	1.2501554680355298e-08	8.80193191968556e-08	0.06060606060606061	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/metabolism	glutathione/metabolism	7.153041936547311e-09	5.0726270889780087e-08	0.005681818181818182	0.18259996156874114	2	2
phospholipid hydroperoxide glutathione peroxidase/metabolism	oleic acid/metabolism	8.925257763969796e-07	3.95587855412095e-06	0.06060606060606061	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/metabolism	cell survival	8.925257763969796e-07	3.95587855412095e-06	0.06060606060606061	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/metabolism	host-pathogen interactions	1.2501554680355298e-08	8.80193191968556e-08	0.06060606060606061	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/metabolism	tuberculosis/metabolism	1.2501554680355298e-08	8.80193191968556e-08	0.06060606060606061	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/metabolism	melanoma/blood	8.925257763969796e-07	3.95587855412095e-06	0.06060606060606061	0.49585123021520294	1	2
phospholipid hydroperoxide glutathione peroxidase/metabolism	ACSL3	8.925257763969796e-07	3.95587855412095e-06	0.06060606060606061	0.49585123021520294	1	2
iron/blood	spleen/pathology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
iron/blood	glutathione	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
iron/blood	liver/pathology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
iron/blood	malondialdehyde/blood	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
iron/blood	kidney	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
autophagy-related proteins/genetics	precursor cell lymphoblastic leukemia-lymphoma/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
autophagy-related proteins/genetics	autophagy/drug effects	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
autophagy-related proteins/genetics	ATG5	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
autophagy-related proteins/genetics	glutathione/metabolism	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
autophagy-related proteins/genetics	flavonolignans/pharmacology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
radiation-protective agents/pharmacology	drug interactions	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
radiation-protective agents/pharmacology	ileum/drug effects	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
radiation-protective agents/pharmacology	necroptosis/drug effects	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
radiation-protective agents/pharmacology	bone marrow/drug effects	4.3519227207355904e-05	0.0001275668183976578	0.12121212121212122	0.49585123021520294	1	2
radiation-protective agents/pharmacology	small molecule libraries/pharmacology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
membrane proteins/genetics	pancreas/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
membrane proteins/genetics	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
membrane proteins/genetics	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
membrane proteins/genetics	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
energy metabolism/drug effects	antineoplastic agents/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
energy metabolism/drug effects	pyruvate dehydrogenase acetyl-transferring kinase/antagonists &amp; inhibitors	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
energy metabolism/drug effects	macrophages/cytology	4.136049573721934e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
energy metabolism/drug effects	dichloroacetic acid/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
energy metabolism/drug effects	neoplasms/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
energy metabolism/drug effects	drug synergism	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
energy metabolism/drug effects	biological products/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
energy metabolism/drug effects	saponins/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
tetrahydrofolate dehydrogenase/genetics	folic acid antagonists/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
tetrahydrofolate dehydrogenase/genetics	gene expression regulation neoplastic	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
reactive oxygen species/metabolism	tumor suppressor protein p53/metabolism	0.0029509424115359284	0.005410980384517282	0.03977272727272727	0.18259996156874114	2	2
antineoplastic agents/chemistry	macrophages/cytology	0.005498155284679007	0.009535103714089757	0.17613636363636365	0.49585123021520294	1	2
antineoplastic agents/chemistry	dichloroacetic acid/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
antineoplastic agents/chemistry	drug synergism	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
antineoplastic agents/chemistry	biological products/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
antineoplastic agents/chemistry	saponins/chemistry	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
antineoplastic agents/chemistry	pyruvate dehydrogenase acetyl-transferring kinase/antagonists &amp; inhibitors	0.0002396003701709004	0.0006063146082656577	0.09090909090909091	0.49585123021520294	1	2
antineoplastic agents/chemistry	leukemia lymphocytic chronic b-cell/immunology	2.3022004953521247e-06	9.993180026285108e-06	0.09090909090909091	0.49585123021520294	1	2
antineoplastic agents/chemistry	heterografts/drug effects	2.3022004953521247e-06	9.993180026285108e-06	0.09090909090909091	0.49585123021520294	1	2
antineoplastic agents/chemistry	vidarabine/analogs &amp; derivatives	2.3022004953521247e-06	9.993180026285108e-06	0.09090909090909091	0.49585123021520294	1	2
antineoplastic agents/chemistry	trisaccharides/chemistry	2.3022004953521247e-06	9.993180026285108e-06	0.09090909090909091	0.49585123021520294	1	2
antineoplastic agents/chemistry	tissue distribution	2.3022004953521247e-06	9.993180026285108e-06	0.09090909090909091	0.49585123021520294	1	2
heart ventricles/diagnostic imaging	nlr family pyrin domain-containing 3 protein/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
heart ventricles/diagnostic imaging	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
heart ventricles/diagnostic imaging	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
heart ventricles/diagnostic imaging	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
heart ventricles/diagnostic imaging	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
heart ventricles/diagnostic imaging	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
heart ventricles/diagnostic imaging	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
heart ventricles/diagnostic imaging	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
drug interactions	ileum/drug effects	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
drug interactions	necroptosis/drug effects	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
drug interactions	bone marrow/drug effects	4.3519227207355904e-05	0.0001275668183976578	0.12121212121212122	0.49585123021520294	1	2
drug interactions	small molecule libraries/pharmacology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
pancreas/metabolism	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreas/metabolism	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
pancreas/metabolism	quinoxalines/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
nlr family pyrin domain-containing 3 protein/metabolism	hypertension pulmonary/chemically induced	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
nlr family pyrin domain-containing 3 protein/metabolism	cells cultured	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
nlr family pyrin domain-containing 3 protein/metabolism	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
nlr family pyrin domain-containing 3 protein/metabolism	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
nlr family pyrin domain-containing 3 protein/metabolism	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
nlr family pyrin domain-containing 3 protein/metabolism	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
nlr family pyrin domain-containing 3 protein/metabolism	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
macrophages/drug effects	iron chelating agents/pharmacology	0.001050416912723895	0.002149775364496817	0.12121212121212122	0.49585123021520294	1	2
macrophages/drug effects	liver x receptors/agonists	0.0049695547136417995	0.00875772426481905	0.12121212121212122	0.49585123021520294	1	2
macrophages/drug effects	listeriosis/etiology	0.0049695547136417995	0.00875772426481905	0.12121212121212122	0.49585123021520294	1	2
macrophages/drug effects	hemeproteins/toxicity	0.0049695547136417995	0.00875772426481905	0.12121212121212122	0.49585123021520294	1	2
macrophages/drug effects	tumor suppressor protein p53/genetics	0.0049695547136417995	0.00875772426481905	0.12121212121212122	0.49585123021520294	1	2
macrophages/drug effects	host-pathogen interactions	0.001050416912723895	0.002149775364496817	0.12121212121212122	0.49585123021520294	1	2
macrophages/drug effects	tuberculosis/metabolism	0.001050416912723895	0.002149775364496817	0.12121212121212122	0.49585123021520294	1	2
macrophages/drug effects	TF	0.0049695547136417995	0.00875772426481905	0.12121212121212122	0.49585123021520294	1	2
benzylidene compounds/chemistry	metal-organic frameworks/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/chemistry	exosomes/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/chemistry	interferon-gamma/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/chemistry	immunogenic cell death/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/chemistry	aniline compounds/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/chemistry	phenol/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/chemistry	cd8-positive t-lymphocytes/cytology	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
benzylidene compounds/chemistry	b7-h1 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/chemistry	programmed cell death 1 receptor/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/chemistry	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
ascorbic acid/pharmacology	t-lymphocytes cytotoxic/metabolism	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
ascorbic acid/pharmacology	neoplasms/diagnostic imaging	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
ascorbic acid/pharmacology	calreticulin/metabolism	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
ascorbic acid/pharmacology	CALR	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
spleen/pathology	malondialdehyde/blood	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
spleen/pathology	kidney	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
spleen/pathology	glutathione	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
spleen/pathology	liver/pathology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
cells cultured	hypertension pulmonary/chemically induced	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
cells cultured	lung/blood supply	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
cells cultured	iron chelating agents/pharmacology	3.1080856240928156e-06	1.3199272715303257e-05	0.06060606060606061	0.49585123021520294	1	2
cells cultured	macrophages/metabolism	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
cells cultured	inflammasomes/metabolism	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
cells cultured	bacterial toxins/metabolism	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
cells cultured	toll-like receptor 4/metabolism	0.003519437482903842	0.0063818265632692595	0.06060606060606061	0.49585123021520294	1	2
cells cultured	host-pathogen interactions	3.1080856240928156e-06	1.3199272715303257e-05	0.06060606060606061	0.49585123021520294	1	2
cells cultured	tuberculosis/metabolism	3.1080856240928156e-06	1.3199272715303257e-05	0.06060606060606061	0.49585123021520294	1	2
metal-organic frameworks/chemistry	exosomes/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
metal-organic frameworks/chemistry	interferon-gamma/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
metal-organic frameworks/chemistry	immunogenic cell death/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
metal-organic frameworks/chemistry	aniline compounds/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
metal-organic frameworks/chemistry	phenol/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
metal-organic frameworks/chemistry	cd8-positive t-lymphocytes/cytology	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
metal-organic frameworks/chemistry	b7-h1 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
metal-organic frameworks/chemistry	programmed cell death 1 receptor/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
metal-organic frameworks/chemistry	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
folic acid antagonists/pharmacology	gene expression regulation neoplastic	0.00041086477812890543	0.0009878881062364124	0.06060606060606061	0.49585123021520294	1	2
ileum/drug effects	necroptosis/drug effects	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
ileum/drug effects	bone marrow/drug effects	4.3519227207355904e-05	0.0001275668183976578	0.12121212121212122	0.49585123021520294	1	2
ileum/drug effects	small molecule libraries/pharmacology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
glutathione/metabolism	precursor cell lymphoblastic leukemia-lymphoma/metabolism	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
glutathione/metabolism	iron chelating agents/pharmacology	6.3096245696003805e-06	2.3328172246650653e-05	0.09090909090909091	0.49585123021520294	1	2
glutathione/metabolism	oleic acid/metabolism	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
glutathione/metabolism	flavonolignans/pharmacology	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
glutathione/metabolism	cell survival	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
glutathione/metabolism	host-pathogen interactions	6.3096245696003805e-06	2.3328172246650653e-05	0.09090909090909091	0.49585123021520294	1	2
glutathione/metabolism	tuberculosis/metabolism	6.3096245696003805e-06	2.3328172246650653e-05	0.09090909090909091	0.49585123021520294	1	2
glutathione/metabolism	melanoma/blood	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
glutathione/metabolism	ACSL3	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
glutathione/metabolism	ATG5	0.00010015305117716533	0.0002704132381783464	0.09090909090909091	0.49585123021520294	1	2
tumor escape/drug effects	b7-h1 antigen/antagonists &amp; inhibitors	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
tumor escape/drug effects	benzylidene compounds/pharmacology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
tumor escape/drug effects	hyaluronic acid/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
tumor escape/drug effects	skin neoplasms/drug therapy	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
tumor escape/drug effects	exosomes/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
tumor escape/drug effects	cell line tumor/transplantation	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
tumor escape/drug effects	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
gene expression regulation neoplastic	t-lymphocytes cytotoxic/immunology	0.002616564743736949	0.0048098376269942785	0.11931818181818181	0.49585123021520294	1	2
gene expression regulation neoplastic	glioblastoma/genetics	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic	brain neoplasms/genetics	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic	cation transport proteins/genetics	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic	hyaluronan receptors/genetics	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic	acetaminophen/pharmacology	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic	heat-shock proteins/genetics	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic	CD44	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic	HSPB1	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic	SLC40A1	9.345130912108424e-06	3.305615417588352e-05	0.06060606060606061	0.49585123021520294	1	2
hypertension pulmonary/chemically induced	lung/blood supply	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hypertension pulmonary/chemically induced	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hypertension pulmonary/chemically induced	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hypertension pulmonary/chemically induced	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hypertension pulmonary/chemically induced	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/biosynthesis	gene expression	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/biosynthesis	NFE2L2	0.00010015305117716533	0.0002704132381783464	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	interferon-gamma/immunology	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	fusion regulatory protein 1 heavy chain/metabolism	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	benzylidene compounds/pharmacology	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	hyaluronic acid/chemistry	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	nivolumab/therapeutic use	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	skin neoplasms/drug therapy	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	exosomes/drug effects	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	melanoma/genetics	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	cysteine/metabolism	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	SLC3A2	9.19693580554437e-05	0.00025272252171537894	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/antagonists &amp; inhibitors	SLC9A1	0.004842334459021824	0.008584933923434476	0.11931818181818181	0.49585123021520294	1	2
autophagy/drug effects	precursor cell lymphoblastic leukemia-lymphoma/metabolism	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
autophagy/drug effects	neoplasms/drug therapy	0.0017748607761071122	0.003489255353429012	0.11931818181818181	0.49585123021520294	1	2
autophagy/drug effects	cd8-positive t-lymphocytes/drug effects	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
autophagy/drug effects	endoplasmic reticulum/drug effects	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
autophagy/drug effects	flavonolignans/pharmacology	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
autophagy/drug effects	ACSL4	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
autophagy/drug effects	AIFM2	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
autophagy/drug effects	ATG5	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
autophagy/drug effects	ATL1	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
autophagy/drug effects	S100A4	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
iron chelating agents/pharmacology	host-pathogen interactions	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
iron chelating agents/pharmacology	tuberculosis/metabolism	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
amino acid transport system y+/metabolism	sorafenib/pharmacology	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	interferon-gamma/immunology	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	hepatocytes/drug effects	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	fusion regulatory protein 1 heavy chain/metabolism	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	nivolumab/therapeutic use	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	melanoma/genetics	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	hypoxia-inducible factor 1 alpha subunit/metabolism	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	cysteine/metabolism	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	FN1	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	HIF1A	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	MMRN1	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	SLC3A2	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
amino acid transport system y+/metabolism	SLC7A11	0.00014596618748896617	0.0003884073144484877	0.011363636363636364	0.18259996156874114	2	2
amino acid transport system y+/metabolism	SLC9A1	0.005704538562607997	0.009846602340032455	0.11931818181818181	0.49585123021520294	1	2
benzylidene compounds/pharmacology	hyaluronic acid/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/pharmacology	skin neoplasms/drug therapy	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/pharmacology	exosomes/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
benzylidene compounds/pharmacology	cell line tumor/transplantation	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
benzylidene compounds/pharmacology	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
macrophages/cytology	pyruvate dehydrogenase acetyl-transferring kinase/antagonists &amp; inhibitors	4.136049573721934e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
macrophages/cytology	urinary bladder neoplasms/pathology	2.708995805456027e-08	1.4601785083254738e-07	0.06060606060606061	0.49585123021520294	1	2
macrophages/cytology	neoplasms/drug therapy	0.0010622317427020356	0.0021724447663461367	0.11931818181818181	0.49585123021520294	1	2
macrophages/cytology	drug synergism	4.136049573721934e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
macrophages/cytology	biological products/chemistry	4.136049573721934e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
macrophages/cytology	saponins/chemistry	4.136049573721934e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
macrophages/cytology	gold/chemistry	2.708995805456027e-08	1.4601785083254738e-07	0.06060606060606061	0.49585123021520294	1	2
macrophages/cytology	adjuvants immunologic/chemistry	2.708995805456027e-08	1.4601785083254738e-07	0.06060606060606061	0.49585123021520294	1	2
macrophages/cytology	dextrans/chemistry	2.708995805456027e-08	1.4601785083254738e-07	0.06060606060606061	0.49585123021520294	1	2
macrophages/cytology	dichloroacetic acid/chemistry	4.136049573721934e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
liver x receptors/agonists	tumor suppressor protein p53/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
liver x receptors/agonists	TF	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
liver x receptors/agonists	TP53	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
liver x receptors/agonists	listeriosis/etiology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
liver x receptors/agonists	hemeproteins/toxicity	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
necroptosis/drug effects	bone marrow/drug effects	4.3519227207355904e-05	0.0001275668183976578	0.12121212121212122	0.49585123021520294	1	2
necroptosis/drug effects	small molecule libraries/pharmacology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
listeriosis/etiology	hemeproteins/toxicity	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
listeriosis/etiology	tumor suppressor protein p53/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
listeriosis/etiology	TF	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
listeriosis/etiology	TP53	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
phenylenediamines/pharmacology	neutrophil infiltration	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
phenylenediamines/pharmacology	toll-like receptor 4/genetics	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
phenylenediamines/pharmacology	myocardium/immunology	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
phenylenediamines/pharmacology	inflammation/drug therapy	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
phenylenediamines/pharmacology	adaptor proteins vesicular transport/genetics	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
phenylenediamines/pharmacology	ventricular function left/drug effects	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
phenylenediamines/pharmacology	neutrophils/immunology	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
phenylenediamines/pharmacology	myocardial reperfusion injury/drug therapy	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
phenylenediamines/pharmacology	TICAM1	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
phenylenediamines/pharmacology	TRIM69	0.0002971974544312417	0.0007288767569926202	0.06060606060606061	0.49585123021520294	1	2
glutathione	liver/pathology	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
glutathione	malondialdehyde/blood	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
glutathione	kidney	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
hemeproteins/toxicity	tumor suppressor protein p53/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
hemeproteins/toxicity	TF	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
hemeproteins/toxicity	TP53	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
quinoxalines/pharmacology	carcinoma pancreatic ductal/metabolism	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
quinoxalines/pharmacology	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
gene expression	NFE2L2	0.00010015305117716533	0.0002704132381783464	0.06060606060606061	0.49585123021520294	1	2
hyaluronic acid/chemistry	skin neoplasms/drug therapy	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
hyaluronic acid/chemistry	exosomes/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
hyaluronic acid/chemistry	cell line tumor/transplantation	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
hyaluronic acid/chemistry	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
lung neoplasms/drug therapy	nf-e2-related factor 2/genetics	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
lung neoplasms/drug therapy	tor serine-threonine kinases/metabolism	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
lung neoplasms/drug therapy	glycogen synthase kinase 3/metabolism	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
lung neoplasms/drug therapy	iron/chemistry	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
lung neoplasms/drug therapy	allografts	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
lung neoplasms/drug therapy	BTRC	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
lung neoplasms/drug therapy	CTLA4	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
lung neoplasms/drug therapy	GABPA	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
lung neoplasms/drug therapy	GSK3B	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
lung neoplasms/drug therapy	MTOR	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
lung neoplasms/drug therapy	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
liver/pathology	malondialdehyde/blood	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
liver/pathology	kidney	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
lung/blood supply	macrophages/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
lung/blood supply	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
lung/blood supply	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
lung/blood supply	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	sorafenib/pharmacology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	hepatocytes/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	MMRN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	FN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hypoxia-inducible factor 1 alpha subunit/metabolism	HIF1A	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
fusion regulatory protein 1 heavy chain/metabolism	interferon-gamma/immunology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
fusion regulatory protein 1 heavy chain/metabolism	nivolumab/therapeutic use	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
fusion regulatory protein 1 heavy chain/metabolism	cd8-positive t-lymphocytes/immunology	0.00441251662780473	0.00787509789910814	0.09090909090909091	0.49585123021520294	1	2
fusion regulatory protein 1 heavy chain/metabolism	melanoma/genetics	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
fusion regulatory protein 1 heavy chain/metabolism	cysteine/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
fusion regulatory protein 1 heavy chain/metabolism	SLC3A2	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
fusion regulatory protein 1 heavy chain/metabolism	SLC7A11	0.00441251662780473	0.00787509789910814	0.12121212121212122	0.49585123021520294	1	2
fusion regulatory protein 1 heavy chain/metabolism	SLC9A1	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
skin neoplasms/drug therapy	exosomes/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
skin neoplasms/drug therapy	cell line tumor/transplantation	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
skin neoplasms/drug therapy	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
nf-e2-related factor 2/genetics	tor serine-threonine kinases/metabolism	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/genetics	glycogen synthase kinase 3/metabolism	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/genetics	iron/chemistry	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/genetics	allografts	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/genetics	BTRC	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/genetics	CTLA4	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/genetics	GABPA	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/genetics	GSK3B	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/genetics	MTOR	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
nf-e2-related factor 2/genetics	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
interferon-gamma/immunology	nivolumab/therapeutic use	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
interferon-gamma/immunology	cd8-positive t-lymphocytes/immunology	0.00441251662780473	0.00787509789910814	0.09090909090909091	0.49585123021520294	1	2
interferon-gamma/immunology	melanoma/genetics	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
interferon-gamma/immunology	cysteine/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
interferon-gamma/immunology	SLC3A2	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
interferon-gamma/immunology	SLC7A11	0.00441251662780473	0.00787509789910814	0.12121212121212122	0.49585123021520294	1	2
interferon-gamma/immunology	SLC9A1	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
flavonolignans/pharmacology	precursor cell lymphoblastic leukemia-lymphoma/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
flavonolignans/pharmacology	ATG5	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
exosomes/drug effects	cell line tumor/transplantation	0.00012305811227752983	0.00032774662844594596	0.06060606060606061	0.49585123021520294	1	2
exosomes/drug effects	CD274	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
macrophages/metabolism	inflammasomes/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
macrophages/metabolism	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
macrophages/metabolism	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
cell line tumor/transplantation	colonic neoplasms/drug therapy	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
cell line tumor/transplantation	tumor suppressor protein p53/metabolism	0.004748209340335929	0.008443492500669872	0.11931818181818181	0.49585123021520294	1	2
cell line tumor/transplantation	t-lymphocytes/immunology	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
cell line tumor/transplantation	membrane proteins/metabolism	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
cell line tumor/transplantation	heme oxygenase-1/metabolism	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
cell line tumor/transplantation	neutral ceramidase/antagonists &amp; inhibitors	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
cell line tumor/transplantation	myeloid-derived suppressor cells/immunology	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
cell line tumor/transplantation	ASAH2	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
cell line tumor/transplantation	HMOX1	0.000212258218726058	0.0005474811022881584	0.06060606060606061	0.49585123021520294	1	2
lipid metabolism/drug effects	gene expression regulation neoplastic/drug effects	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
lipid metabolism/drug effects	amino acid transport system y+/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
lipid metabolism/drug effects	antineoplastic agents immunological/administration &amp; dosage	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
lipid metabolism/drug effects	ATM	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
lipid metabolism/drug effects	SLC7A11	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
lipid metabolism/drug effects	SLC9A1	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
lipid metabolism/drug effects	cd8-positive t-lymphocytes/immunology	0.0019835623240943567	0.003832976966388504	0.09090909090909091	0.49585123021520294	1	2
glutathione peroxidase/therapeutic use	b-lymphocytes/metabolism	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
glutathione peroxidase/therapeutic use	cytoskeletal proteins/metabolism	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
glutathione peroxidase/therapeutic use	BDKRB2	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
b-lymphocytes/metabolism	cytoskeletal proteins/metabolism	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
b-lymphocytes/metabolism	BDKRB2	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
bone marrow/drug effects	small molecule libraries/pharmacology	4.3519227207355904e-05	0.0001275668183976578	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	mutant proteins/metabolism	0.0009481193198297433	0.001944470493560233	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	multiple myeloma/genetics	0.0009481193198297433	0.001944470493560233	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	osteoprotegerin/genetics	0.0009481193198297433	0.001944470493560233	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	tnf-related apoptosis-inducing ligand/genetics	0.0009481193198297433	0.001944470493560233	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	recombinant proteins/metabolism	0.0009481193198297433	0.001944470493560233	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	TNFRSF11B	0.0009481193198297433	0.001944470493560233	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	leukemia lymphocytic chronic b-cell/immunology	4.3519227207355904e-05	0.0001275668183976578	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	heterografts/drug effects	4.3519227207355904e-05	0.0001275668183976578	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	vidarabine/analogs &amp; derivatives	4.3519227207355904e-05	0.0001275668183976578	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	trisaccharides/chemistry	4.3519227207355904e-05	0.0001275668183976578	0.12121212121212122	0.49585123021520294	1	2
bone marrow/drug effects	tissue distribution	4.3519227207355904e-05	0.0001275668183976578	0.12121212121212122	0.49585123021520294	1	2
t-lymphocytes cytotoxic/metabolism	neoplasms/diagnostic imaging	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
t-lymphocytes cytotoxic/metabolism	calreticulin/metabolism	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
t-lymphocytes cytotoxic/metabolism	CALR	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
oleic acid/metabolism	cell survival	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
oleic acid/metabolism	oxidative stress/drug effects	0.00024787161677153335	0.0006234924514176263	0.06060606060606061	0.49585123021520294	1	2
oleic acid/metabolism	melanoma/blood	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
oleic acid/metabolism	ACSL3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
dichloroacetic acid/chemistry	pyruvate dehydrogenase acetyl-transferring kinase/antagonists &amp; inhibitors	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
dichloroacetic acid/chemistry	neoplasms/drug therapy	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
dichloroacetic acid/chemistry	drug synergism	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
dichloroacetic acid/chemistry	biological products/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
dichloroacetic acid/chemistry	saponins/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
urinary bladder neoplasms/pathology	gold/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
urinary bladder neoplasms/pathology	adjuvants immunologic/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
urinary bladder neoplasms/pathology	dextrans/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
FN1	sorafenib/pharmacology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
FN1	hepatocytes/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
FN1	HIF1A	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
FN1	MMRN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
malondialdehyde/blood	kidney	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
drug resistance neoplasm	basic-leucine zipper transcription factors/analysis	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
drug resistance neoplasm	GGT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
inflammasomes/metabolism	bacterial toxins/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
inflammasomes/metabolism	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
ATG5	precursor cell lymphoblastic leukemia-lymphoma/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
tumor suppressor protein p53/genetics	TF	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
tumor suppressor protein p53/genetics	TP53	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
antibodies monoclonal humanized/pharmacology	multiple myeloma/drug therapy	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
antibodies monoclonal humanized/pharmacology	cd36 antigens/antagonists &amp; inhibitors	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
antibodies monoclonal humanized/pharmacology	cd8-positive t-lymphocytes/cytology	0.0004356498062166869	0.0009950079515128947	0.09090909090909091	0.49585123021520294	1	2
antibodies monoclonal humanized/pharmacology	fatty acids/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
antibodies monoclonal humanized/pharmacology	CD36	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
tor serine-threonine kinases/metabolism	glycogen synthase kinase 3/metabolism	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
tor serine-threonine kinases/metabolism	iron/chemistry	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
tor serine-threonine kinases/metabolism	allografts	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
tor serine-threonine kinases/metabolism	BTRC	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
tor serine-threonine kinases/metabolism	CTLA4	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
tor serine-threonine kinases/metabolism	GABPA	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
tor serine-threonine kinases/metabolism	GSK3B	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
tor serine-threonine kinases/metabolism	MTOR	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
tor serine-threonine kinases/metabolism	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
neoplasms/drug therapy	pyruvate dehydrogenase acetyl-transferring kinase/antagonists &amp; inhibitors	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
neoplasms/drug therapy	saponins/chemistry	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
neoplasms/drug therapy	cd8-positive t-lymphocytes/drug effects	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
neoplasms/drug therapy	endoplasmic reticulum/drug effects	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
neoplasms/drug therapy	ACSL4	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
neoplasms/drug therapy	AIFM2	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
neoplasms/drug therapy	ATL1	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
neoplasms/drug therapy	S100A4	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
neoplasms/drug therapy	drug synergism	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
neoplasms/drug therapy	biological products/chemistry	1.629191080620984e-05	4.897558069731927e-05	0.06060606060606061	0.49585123021520294	1	2
HIF1A	sorafenib/pharmacology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
HIF1A	hepatocytes/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
HIF1A	MMRN1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
cell survival	oxidative stress/drug effects	0.00024787161677153335	0.0006234924514176263	0.06060606060606061	0.49585123021520294	1	2
cell survival	melanoma/blood	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
cell survival	ACSL3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
host-pathogen interactions	tuberculosis/metabolism	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
CD274	exosomes/metabolism	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
CD274	interferon-gamma/metabolism	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
CD274	aniline compounds/chemistry	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
CD274	immunogenic cell death/drug effects	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
CD274	programmed cell death 1 receptor/metabolism	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
CD274	phenol/chemistry	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
CD274	b7-h1 antigen/metabolism	0.005296226357846323	0.009190326751852433	0.09090909090909091	0.49585123021520294	1	2
glycogen synthase kinase 3/metabolism	iron/chemistry	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
glycogen synthase kinase 3/metabolism	allografts	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
glycogen synthase kinase 3/metabolism	BTRC	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
glycogen synthase kinase 3/metabolism	CTLA4	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
glycogen synthase kinase 3/metabolism	GABPA	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
glycogen synthase kinase 3/metabolism	GSK3B	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
glycogen synthase kinase 3/metabolism	MTOR	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
glycogen synthase kinase 3/metabolism	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
basic-leucine zipper transcription factors/analysis	GGT1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
multiple myeloma/drug therapy	cd36 antigens/antagonists &amp; inhibitors	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
multiple myeloma/drug therapy	gene expression regulation neoplastic/drug effects	0.0022270932568636548	0.004096459659343585	0.11931818181818181	0.49585123021520294	1	2
multiple myeloma/drug therapy	fatty acids/metabolism	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
multiple myeloma/drug therapy	CD36	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
MMRN1	sorafenib/pharmacology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
MMRN1	hepatocytes/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
drug synergism	pyruvate dehydrogenase acetyl-transferring kinase/antagonists &amp; inhibitors	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
drug synergism	biological products/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
drug synergism	saponins/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
carcinoma pancreatic ductal/metabolism	spiro compounds/pharmacology	1.5792778972234522e-05	4.8617310162433266e-05	0.030303030303030304	0.49585123021520294	1	2
cd36 antigens/antagonists &amp; inhibitors	cd8-positive t-lymphocytes/cytology	0.0004356498062166869	0.0009950079515128947	0.09090909090909091	0.49585123021520294	1	2
cd36 antigens/antagonists &amp; inhibitors	fatty acids/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
cd36 antigens/antagonists &amp; inhibitors	CD36	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
biological products/chemistry	pyruvate dehydrogenase acetyl-transferring kinase/antagonists &amp; inhibitors	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
biological products/chemistry	saponins/chemistry	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
bacterial toxins/metabolism	toll-like receptor 4/metabolism	0.00046149706211862096	0.0009950079515128947	0.030303030303030304	0.49585123021520294	1	2
iron/chemistry	allografts	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
iron/chemistry	BTRC	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
iron/chemistry	CTLA4	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
iron/chemistry	GABPA	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
iron/chemistry	GSK3B	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
iron/chemistry	MTOR	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
iron/chemistry	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	interferon-gamma/metabolism	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	fatty acids/metabolism	0.0004356498062166869	0.0009950079515128947	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	exosomes/metabolism	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	aniline compounds/chemistry	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	b7-h1 antigen/metabolism	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	programmed cell death 1 receptor/metabolism	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	immunogenic cell death/drug effects	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	CD36	0.0004356498062166869	0.0009950079515128947	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	skin neoplasms/immunology	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	programmed cell death 1 receptor/antagonists &amp; inhibitors	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	antibodies monoclonal humanized/administration &amp; dosage	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	neoplasm metastasis	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	leukocyte common antigens/metabolism	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	t-lymphocyte subsets/cytology	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	melanoma/immunology	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	ctla-4 antigen/metabolism	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	phenotype	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/cytology	phenol/chemistry	0.001185426255781441	0.0023928048496329084	0.09090909090909091	0.49585123021520294	1	2
oxidative stress/drug effects	melanoma/blood	0.00024787161677153335	0.0006234924514176263	0.06060606060606061	0.49585123021520294	1	2
oxidative stress/drug effects	ACSL3	0.00024787161677153335	0.0006234924514176263	0.06060606060606061	0.49585123021520294	1	2
SLC7A11	killer cells natural/metabolism	0.0006570549362086009	0.0013675478622785803	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	diterpenes/pharmacology	0.0006570549362086009	0.0013675478622785803	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	lymphoma t-cell	0.0006570549362086009	0.0013675478622785803	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	asparaginase	0.0006570549362086009	0.0013675478622785803	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	amino acid transport system y+/genetics	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	cisplatin	0.0006570549362086009	0.0013675478622785803	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	nivolumab/therapeutic use	0.00441251662780473	0.00787509789910814	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	melanoma/genetics	0.00441251662780473	0.00787509789910814	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	cysteine/metabolism	0.00441251662780473	0.00787509789910814	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	SLC9A1	5.2485890851383665e-05	0.00014996696774332246	0.011363636363636364	0.18259996156874114	2	2
SLC7A11	antineoplastic agents immunological/administration &amp; dosage	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	ATM	0.0019835623240943567	0.003832976966388504	0.12121212121212122	0.49585123021520294	1	2
SLC7A11	SLC3A2	0.00441251662780473	0.00787509789910814	0.12121212121212122	0.49585123021520294	1	2
melanoma/blood	ACSL3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
allografts	BTRC	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
allografts	CTLA4	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
allografts	GABPA	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
allografts	GSK3B	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
allografts	MTOR	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
allografts	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
exosomes/metabolism	b7-h1 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
exosomes/metabolism	programmed cell death 1 receptor/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
exosomes/metabolism	interferon-gamma/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
exosomes/metabolism	immunogenic cell death/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
exosomes/metabolism	aniline compounds/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
exosomes/metabolism	phenol/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
fatty acids/metabolism	CD36	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
interferon-gamma/metabolism	immunogenic cell death/drug effects	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
interferon-gamma/metabolism	aniline compounds/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
interferon-gamma/metabolism	phenol/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
interferon-gamma/metabolism	b7-h1 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
interferon-gamma/metabolism	programmed cell death 1 receptor/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
saponins/chemistry	pyruvate dehydrogenase acetyl-transferring kinase/antagonists &amp; inhibitors	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
cytoskeletal proteins/metabolism	BDKRB2	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
nivolumab/therapeutic use	cd8-positive t-lymphocytes/immunology	0.00441251662780473	0.00787509789910814	0.09090909090909091	0.49585123021520294	1	2
nivolumab/therapeutic use	melanoma/genetics	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
nivolumab/therapeutic use	cysteine/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
nivolumab/therapeutic use	SLC3A2	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
nivolumab/therapeutic use	SLC9A1	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
cd8-positive t-lymphocytes/drug effects	endoplasmic reticulum/drug effects	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
cd8-positive t-lymphocytes/drug effects	ACSL4	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
cd8-positive t-lymphocytes/drug effects	AIFM2	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
cd8-positive t-lymphocytes/drug effects	ATL1	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
cd8-positive t-lymphocytes/drug effects	S100A4	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
immunogenic cell death/drug effects	aniline compounds/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunogenic cell death/drug effects	phenol/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunogenic cell death/drug effects	b7-h1 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
immunogenic cell death/drug effects	programmed cell death 1 receptor/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
aniline compounds/chemistry	phenol/chemistry	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
aniline compounds/chemistry	b7-h1 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
aniline compounds/chemistry	programmed cell death 1 receptor/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
neoplasms/diagnostic imaging	calreticulin/metabolism	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
neoplasms/diagnostic imaging	CALR	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
cd8-positive t-lymphocytes/immunology	melanoma/genetics	0.00441251662780473	0.00787509789910814	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/immunology	amino acid transport system y+/genetics	0.0019835623240943567	0.003832976966388504	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/immunology	antineoplastic agents immunological/administration &amp; dosage	0.0019835623240943567	0.003832976966388504	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/immunology	cysteine/metabolism	0.00441251662780473	0.00787509789910814	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/immunology	ATM	0.0019835623240943567	0.003832976966388504	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/immunology	SLC3A2	0.00441251662780473	0.00787509789910814	0.09090909090909091	0.49585123021520294	1	2
cd8-positive t-lymphocytes/immunology	SLC9A1	5.2485890851383665e-05	0.00014996696774332246	0.005681818181818182	0.18259996156874114	2	2
phenol/chemistry	b7-h1 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
phenol/chemistry	programmed cell death 1 receptor/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
endoplasmic reticulum/drug effects	ACSL4	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
endoplasmic reticulum/drug effects	AIFM2	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
endoplasmic reticulum/drug effects	ATL1	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
endoplasmic reticulum/drug effects	S100A4	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
TF	TP53	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
TP53	colonic neoplasms/drug therapy	0.005066261860780963	0.008885583227817863	0.12121212121212122	0.49585123021520294	1	2
TP53	membrane proteins/metabolism	0.005066261860780963	0.008885583227817863	0.12121212121212122	0.49585123021520294	1	2
TP53	tumor suppressor protein p53/metabolism	2.330015635065852e-05	6.975825039673247e-05	0.011363636363636364	0.18259996156874114	2	2
TP53	neutral ceramidase/antagonists &amp; inhibitors	0.005066261860780963	0.008885583227817863	0.12121212121212122	0.49585123021520294	1	2
TP53	killer cells natural/metabolism	0.0005023126591775506	0.001079055588291629	0.12121212121212122	0.49585123021520294	1	2
TP53	diterpenes/pharmacology	0.0005023126591775506	0.001079055588291629	0.12121212121212122	0.49585123021520294	1	2
TP53	t-lymphocytes/immunology	0.005066261860780963	0.008885583227817863	0.12121212121212122	0.49585123021520294	1	2
TP53	heme oxygenase-1/metabolism	0.005066261860780963	0.008885583227817863	0.12121212121212122	0.49585123021520294	1	2
TP53	lymphoma t-cell	0.0005023126591775506	0.001079055588291629	0.12121212121212122	0.49585123021520294	1	2
TP53	asparaginase	0.0005023126591775506	0.001079055588291629	0.12121212121212122	0.49585123021520294	1	2
TP53	lymphocytes tumor-infiltrating/immunology	0.0015462248079950447	0.0030788495331051536	0.03262463343108504	0.18259996156874114	2	2
TP53	cisplatin	0.0005023126591775506	0.001079055588291629	0.12121212121212122	0.49585123021520294	1	2
TP53	myeloid-derived suppressor cells/immunology	0.005066261860780963	0.008885583227817863	0.12121212121212122	0.49585123021520294	1	2
TP53	ASAH2	0.005066261860780963	0.008885583227817863	0.12121212121212122	0.49585123021520294	1	2
TP53	HMOX1	0.005066261860780963	0.008885583227817863	0.12121212121212122	0.49585123021520294	1	2
TP53	carcinogenesis/immunology	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
TP53	imidazoles/administration &amp; dosage	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
TP53	tumor suppressor protein p53/biosynthesis	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
TP53	piperazines/administration &amp; dosage	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
TP53	immunity innate/genetics	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
TP53	apoptosis/immunology	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
TP53	TLR3	0.001581207563287057	0.0031147883927401666	0.12121212121212122	0.49585123021520294	1	2
cell movement/drug effects	benzylamines	0.00441251662780473	0.00787509789910814	0.06060606060606061	0.49585123021520294	1	2
cell movement/drug effects	leukemia myeloid acute/drug therapy	0.00441251662780473	0.00787509789910814	0.06060606060606061	0.49585123021520294	1	2
cell movement/drug effects	receptors cxcr4/antagonists &amp; inhibitors	0.00441251662780473	0.00787509789910814	0.06060606060606061	0.49585123021520294	1	2
cell movement/drug effects	cyclams	0.00441251662780473	0.00787509789910814	0.06060606060606061	0.49585123021520294	1	2
cell movement/drug effects	transforming growth factor beta/antagonists &amp; inhibitors	0.00441251662780473	0.00787509789910814	0.06060606060606061	0.49585123021520294	1	2
cell movement/drug effects	cytarabine/pharmacology	0.00441251662780473	0.00787509789910814	0.06060606060606061	0.49585123021520294	1	2
cell movement/drug effects	chemokine cxcl12/metabolism	0.00441251662780473	0.00787509789910814	0.06060606060606061	0.49585123021520294	1	2
cell movement/drug effects	antibodies neutralizing/metabolism	0.00441251662780473	0.00787509789910814	0.06060606060606061	0.49585123021520294	1	2
cell movement/drug effects	CXCL12	0.00441251662780473	0.00787509789910814	0.06060606060606061	0.49585123021520294	1	2
cell movement/drug effects	CXCR4	0.00441251662780473	0.00787509789910814	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic/drug effects	amino acid transport system y+/genetics	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic/drug effects	antineoplastic agents immunological/administration &amp; dosage	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic/drug effects	ATM	7.0427111389381736e-06	2.5556965329093764e-05	0.06060606060606061	0.49585123021520294	1	2
gene expression regulation neoplastic/drug effects	SLC9A1	0.0027480089335699676	0.00504515925857543	0.11931818181818181	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	colonic neoplasms/drug therapy	0.0020381358493498647	0.003917853562793372	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	t-lymphocytes/immunology	0.0020381358493498647	0.003917853562793372	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	membrane proteins/metabolism	0.0020381358493498647	0.003917853562793372	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	heme oxygenase-1/metabolism	0.0020381358493498647	0.003917853562793372	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	neutral ceramidase/antagonists &amp; inhibitors	0.0020381358493498647	0.003917853562793372	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	myeloid-derived suppressor cells/immunology	0.0020381358493498647	0.003917853562793372	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	ASAH2	0.0020381358493498647	0.003917853562793372	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	HMOX1	0.0020381358493498647	0.003917853562793372	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	skin neoplasms/immunology	0.0013737295022002716	0.002737228114404468	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	programmed cell death 1 receptor/antagonists &amp; inhibitors	0.0013737295022002716	0.002737228114404468	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	antibodies monoclonal humanized/administration &amp; dosage	0.0013737295022002716	0.002737228114404468	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	neoplasm metastasis	0.0013737295022002716	0.002737228114404468	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	leukocyte common antigens/metabolism	0.0013737295022002716	0.002737228114404468	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	t-lymphocyte subsets/cytology	0.0013737295022002716	0.002737228114404468	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	melanoma/immunology	0.0013737295022002716	0.002737228114404468	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	ctla-4 antigen/metabolism	0.0013737295022002716	0.002737228114404468	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	phenotype	0.0013737295022002716	0.002737228114404468	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	tumor microenvironment/immunology	4.781786569485469e-06	1.776868418433805e-05	0.005681818181818182	0.18259996156874114	2	2
lymphocytes tumor-infiltrating/immunology	carcinogenesis/immunology	0.0005164751544068924	0.0011038390554970836	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	imidazoles/administration &amp; dosage	0.0005164751544068924	0.0011038390554970836	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	tumor suppressor protein p53/biosynthesis	0.0005164751544068924	0.0011038390554970836	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	piperazines/administration &amp; dosage	0.0005164751544068924	0.0011038390554970836	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	immunity innate/genetics	0.0005164751544068924	0.0011038390554970836	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	apoptosis/immunology	0.0005164751544068924	0.0011038390554970836	0.09090909090909091	0.49585123021520294	1	2
lymphocytes tumor-infiltrating/immunology	TLR3	0.0005164751544068924	0.0011038390554970836	0.09090909090909091	0.49585123021520294	1	2
melanoma/genetics	cysteine/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
melanoma/genetics	SLC3A2	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
melanoma/genetics	SLC9A1	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
gold/chemistry	adjuvants immunologic/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
gold/chemistry	dextrans/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
amino acid transport system y+/genetics	antineoplastic agents immunological/administration &amp; dosage	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
amino acid transport system y+/genetics	ATM	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
amino acid transport system y+/genetics	SLC9A1	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
antineoplastic agents immunological/administration &amp; dosage	ATM	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
antineoplastic agents immunological/administration &amp; dosage	SLC9A1	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
adjuvants immunologic/chemistry	dextrans/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
calreticulin/metabolism	CALR	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
cysteine/metabolism	SLC3A2	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
cysteine/metabolism	SLC9A1	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
b7-h1 antigen/metabolism	programmed cell death 1 receptor/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
ACSL4	AIFM2	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
ACSL4	ATL1	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
ACSL4	S100A4	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
AIFM2	ATL1	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
AIFM2	S100A4	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
mutant proteins/metabolism	multiple myeloma/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
mutant proteins/metabolism	osteoprotegerin/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
mutant proteins/metabolism	tnf-related apoptosis-inducing ligand/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
mutant proteins/metabolism	mutation	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
mutant proteins/metabolism	recombinant proteins/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
mutant proteins/metabolism	TNFRSF11B	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
ATL1	S100A4	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
ATM	SLC9A1	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
multiple myeloma/genetics	osteoprotegerin/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
multiple myeloma/genetics	tnf-related apoptosis-inducing ligand/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
multiple myeloma/genetics	mutation	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
multiple myeloma/genetics	recombinant proteins/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
multiple myeloma/genetics	TNFRSF11B	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
osteoprotegerin/genetics	tnf-related apoptosis-inducing ligand/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
osteoprotegerin/genetics	mutation	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
osteoprotegerin/genetics	recombinant proteins/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
osteoprotegerin/genetics	TNFRSF11B	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
BTRC	CTLA4	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
BTRC	GABPA	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
BTRC	GSK3B	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
BTRC	MTOR	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
BTRC	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	brain neoplasms/genetics	9.39102035468764e-07	4.106652734598176e-06	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	glioblastoma/genetics	9.39102035468764e-07	4.106652734598176e-06	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	hyaluronan receptors/genetics	9.39102035468764e-07	4.106652734598176e-06	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	cation transport proteins/genetics	9.39102035468764e-07	4.106652734598176e-06	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	acetaminophen/pharmacology	9.39102035468764e-07	4.106652734598176e-06	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	heat-shock proteins/genetics	9.39102035468764e-07	4.106652734598176e-06	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	CD44	9.39102035468764e-07	4.106652734598176e-06	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	HSPB1	9.39102035468764e-07	4.106652734598176e-06	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	SLC40A1	9.39102035468764e-07	4.106652734598176e-06	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	mutation	0.0010861342069766744	0.0022197867855085784	0.11931818181818181	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	tumor microenvironment/immunology	0.0017415513102746472	0.0034283515091225996	0.11931818181818181	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	carcinogenesis/immunology	2.737930955509782e-06	1.1763110659949326e-05	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	imidazoles/administration &amp; dosage	2.737930955509782e-06	1.1763110659949326e-05	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	tumor suppressor protein p53/biosynthesis	2.737930955509782e-06	1.1763110659949326e-05	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	piperazines/administration &amp; dosage	2.737930955509782e-06	1.1763110659949326e-05	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	immunity innate/genetics	2.737930955509782e-06	1.1763110659949326e-05	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	apoptosis/immunology	2.737930955509782e-06	1.1763110659949326e-05	0.06060606060606061	0.49585123021520294	1	2
t-lymphocytes cytotoxic/immunology	TLR3	2.737930955509782e-06	1.1763110659949326e-05	0.06060606060606061	0.49585123021520294	1	2
brain neoplasms/genetics	glioblastoma/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
brain neoplasms/genetics	hyaluronan receptors/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
brain neoplasms/genetics	cation transport proteins/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
brain neoplasms/genetics	acetaminophen/pharmacology	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
brain neoplasms/genetics	heat-shock proteins/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
brain neoplasms/genetics	CD44	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
brain neoplasms/genetics	HSPB1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
brain neoplasms/genetics	SLC40A1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
tnf-related apoptosis-inducing ligand/genetics	mutation	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
tnf-related apoptosis-inducing ligand/genetics	recombinant proteins/metabolism	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
tnf-related apoptosis-inducing ligand/genetics	TNFRSF11B	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
mutation	recombinant proteins/metabolism	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
mutation	tumor microenvironment/immunology	0.0022077059921027375	0.004096459659343585	0.11931818181818181	0.49585123021520294	1	2
mutation	TNFRSF11B	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
mutation	carcinogenesis/immunology	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
mutation	imidazoles/administration &amp; dosage	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
mutation	tumor suppressor protein p53/biosynthesis	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
mutation	piperazines/administration &amp; dosage	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
mutation	immunity innate/genetics	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
mutation	apoptosis/immunology	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
mutation	TLR3	4.476668622355184e-06	1.7321223756741657e-05	0.06060606060606061	0.49585123021520294	1	2
recombinant proteins/metabolism	TNFRSF11B	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
CTLA4	GABPA	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
CTLA4	GSK3B	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
CTLA4	MTOR	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
CTLA4	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
GABPA	GSK3B	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
GABPA	MTOR	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
GABPA	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
glioblastoma/genetics	hyaluronan receptors/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
glioblastoma/genetics	cation transport proteins/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
glioblastoma/genetics	acetaminophen/pharmacology	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
glioblastoma/genetics	heat-shock proteins/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
glioblastoma/genetics	CD44	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
glioblastoma/genetics	HSPB1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
glioblastoma/genetics	SLC40A1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
GSK3B	MTOR	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
GSK3B	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
MTOR	PRKAA2	0.0022270932568636548	0.004096459659343585	0.030303030303030304	0.49585123021520294	1	2
SLC3A2	SLC9A1	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
sorafenib/pharmacology	hepatocytes/drug effects	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
hyaluronan receptors/genetics	CD44	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
hyaluronan receptors/genetics	HSPB1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
hyaluronan receptors/genetics	SLC40A1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
hyaluronan receptors/genetics	cation transport proteins/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
hyaluronan receptors/genetics	acetaminophen/pharmacology	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
hyaluronan receptors/genetics	heat-shock proteins/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
colonic neoplasms/drug therapy	myeloid-derived suppressor cells/immunology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
colonic neoplasms/drug therapy	ASAH2	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
colonic neoplasms/drug therapy	HMOX1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
colonic neoplasms/drug therapy	tumor suppressor protein p53/metabolism	6.276739991117886e-05	0.00017796190552851575	0.06060606060606061	0.49585123021520294	1	2
colonic neoplasms/drug therapy	membrane proteins/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
colonic neoplasms/drug therapy	neutral ceramidase/antagonists &amp; inhibitors	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
colonic neoplasms/drug therapy	heme oxygenase-1/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
colonic neoplasms/drug therapy	t-lymphocytes/immunology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
benzylamines	leukemia myeloid acute/drug therapy	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
benzylamines	receptors cxcr4/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
benzylamines	cyclams	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
benzylamines	transforming growth factor beta/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
benzylamines	cytarabine/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
benzylamines	chemokine cxcl12/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
benzylamines	antibodies neutralizing/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
benzylamines	CXCL12	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
benzylamines	CXCR4	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
skin neoplasms/immunology	programmed cell death 1 receptor/antagonists &amp; inhibitors	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
skin neoplasms/immunology	antibodies monoclonal humanized/administration &amp; dosage	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
skin neoplasms/immunology	neoplasm metastasis	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
skin neoplasms/immunology	leukocyte common antigens/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
skin neoplasms/immunology	t-lymphocyte subsets/cytology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
skin neoplasms/immunology	melanoma/immunology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
skin neoplasms/immunology	ctla-4 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
skin neoplasms/immunology	phenotype	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
skin neoplasms/immunology	tumor microenvironment/immunology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
programmed cell death 1 receptor/antagonists &amp; inhibitors	antibodies monoclonal humanized/administration &amp; dosage	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
programmed cell death 1 receptor/antagonists &amp; inhibitors	neoplasm metastasis	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
programmed cell death 1 receptor/antagonists &amp; inhibitors	leukocyte common antigens/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
programmed cell death 1 receptor/antagonists &amp; inhibitors	t-lymphocyte subsets/cytology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
programmed cell death 1 receptor/antagonists &amp; inhibitors	melanoma/immunology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
programmed cell death 1 receptor/antagonists &amp; inhibitors	ctla-4 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
programmed cell death 1 receptor/antagonists &amp; inhibitors	phenotype	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
programmed cell death 1 receptor/antagonists &amp; inhibitors	tumor microenvironment/immunology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
antibodies monoclonal humanized/administration &amp; dosage	neoplasm metastasis	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
antibodies monoclonal humanized/administration &amp; dosage	leukocyte common antigens/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
antibodies monoclonal humanized/administration &amp; dosage	t-lymphocyte subsets/cytology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
antibodies monoclonal humanized/administration &amp; dosage	melanoma/immunology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
antibodies monoclonal humanized/administration &amp; dosage	ctla-4 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
antibodies monoclonal humanized/administration &amp; dosage	phenotype	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
antibodies monoclonal humanized/administration &amp; dosage	tumor microenvironment/immunology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
cation transport proteins/genetics	acetaminophen/pharmacology	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
cation transport proteins/genetics	heat-shock proteins/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
cation transport proteins/genetics	CD44	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
cation transport proteins/genetics	HSPB1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
cation transport proteins/genetics	SLC40A1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
leukemia myeloid acute/drug therapy	receptors cxcr4/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
leukemia myeloid acute/drug therapy	cyclams	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
leukemia myeloid acute/drug therapy	transforming growth factor beta/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
leukemia myeloid acute/drug therapy	cytarabine/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
leukemia myeloid acute/drug therapy	chemokine cxcl12/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
leukemia myeloid acute/drug therapy	antibodies neutralizing/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
leukemia myeloid acute/drug therapy	CXCL12	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
leukemia myeloid acute/drug therapy	CXCR4	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis	leukocyte common antigens/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis	t-lymphocyte subsets/cytology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis	melanoma/immunology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis	ctla-4 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis	phenotype	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
neoplasm metastasis	tumor microenvironment/immunology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
acetaminophen/pharmacology	heat-shock proteins/genetics	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
acetaminophen/pharmacology	CD44	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
acetaminophen/pharmacology	HSPB1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
acetaminophen/pharmacology	SLC40A1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
receptors cxcr4/antagonists &amp; inhibitors	cyclams	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
receptors cxcr4/antagonists &amp; inhibitors	transforming growth factor beta/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
receptors cxcr4/antagonists &amp; inhibitors	cytarabine/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
receptors cxcr4/antagonists &amp; inhibitors	chemokine cxcl12/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
receptors cxcr4/antagonists &amp; inhibitors	antibodies neutralizing/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
receptors cxcr4/antagonists &amp; inhibitors	CXCL12	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
receptors cxcr4/antagonists &amp; inhibitors	CXCR4	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
leukocyte common antigens/metabolism	t-lymphocyte subsets/cytology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
leukocyte common antigens/metabolism	melanoma/immunology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
leukocyte common antigens/metabolism	ctla-4 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
leukocyte common antigens/metabolism	phenotype	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
leukocyte common antigens/metabolism	tumor microenvironment/immunology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
cyclams	transforming growth factor beta/antagonists &amp; inhibitors	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
cyclams	cytarabine/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
cyclams	chemokine cxcl12/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
cyclams	antibodies neutralizing/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
cyclams	CXCL12	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
cyclams	CXCR4	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
t-lymphocyte subsets/cytology	melanoma/immunology	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
t-lymphocyte subsets/cytology	ctla-4 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
t-lymphocyte subsets/cytology	phenotype	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
t-lymphocyte subsets/cytology	tumor microenvironment/immunology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
melanoma/immunology	ctla-4 antigen/metabolism	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
melanoma/immunology	phenotype	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
melanoma/immunology	tumor microenvironment/immunology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
transforming growth factor beta/antagonists &amp; inhibitors	CXCL12	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
transforming growth factor beta/antagonists &amp; inhibitors	CXCR4	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
transforming growth factor beta/antagonists &amp; inhibitors	cytarabine/pharmacology	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
transforming growth factor beta/antagonists &amp; inhibitors	chemokine cxcl12/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
transforming growth factor beta/antagonists &amp; inhibitors	antibodies neutralizing/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
ctla-4 antigen/metabolism	phenotype	2.2951121447789546e-08	1.2485240373538748e-07	0.030303030303030304	0.49585123021520294	1	2
ctla-4 antigen/metabolism	tumor microenvironment/immunology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
cytarabine/pharmacology	chemokine cxcl12/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
cytarabine/pharmacology	antibodies neutralizing/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
cytarabine/pharmacology	CXCL12	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
cytarabine/pharmacology	CXCR4	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
phenotype	tumor microenvironment/immunology	4.8122088063484725e-05	0.00013776586106112407	0.06060606060606061	0.49585123021520294	1	2
chemokine cxcl12/metabolism	antibodies neutralizing/metabolism	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
chemokine cxcl12/metabolism	CXCL12	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
chemokine cxcl12/metabolism	CXCR4	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
tumor microenvironment/immunology	carcinogenesis/immunology	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment/immunology	imidazoles/administration &amp; dosage	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment/immunology	tumor suppressor protein p53/biosynthesis	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment/immunology	piperazines/administration &amp; dosage	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment/immunology	immunity innate/genetics	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment/immunology	apoptosis/immunology	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
tumor microenvironment/immunology	TLR3	1.0707693532174822e-05	3.7073814194341765e-05	0.06060606060606061	0.49585123021520294	1	2
myeloid-derived suppressor cells/immunology	tumor suppressor protein p53/metabolism	6.276739991117886e-05	0.00017796190552851575	0.06060606060606061	0.49585123021520294	1	2
myeloid-derived suppressor cells/immunology	t-lymphocytes/immunology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
myeloid-derived suppressor cells/immunology	membrane proteins/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
myeloid-derived suppressor cells/immunology	heme oxygenase-1/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
myeloid-derived suppressor cells/immunology	neutral ceramidase/antagonists &amp; inhibitors	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
myeloid-derived suppressor cells/immunology	ASAH2	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
myeloid-derived suppressor cells/immunology	HMOX1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
antibodies neutralizing/metabolism	CXCL12	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
antibodies neutralizing/metabolism	CXCR4	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
heat-shock proteins/genetics	CD44	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
heat-shock proteins/genetics	HSPB1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
heat-shock proteins/genetics	SLC40A1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
CXCL12	CXCR4	4.6554835173573395e-06	1.7321223756741657e-05	0.030303030303030304	0.49585123021520294	1	2
leukemia lymphocytic chronic b-cell/immunology	heterografts/drug effects	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
leukemia lymphocytic chronic b-cell/immunology	vidarabine/analogs &amp; derivatives	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
leukemia lymphocytic chronic b-cell/immunology	trisaccharides/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
leukemia lymphocytic chronic b-cell/immunology	tissue distribution	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
ASAH2	tumor suppressor protein p53/metabolism	6.276739991117886e-05	0.00017796190552851575	0.06060606060606061	0.49585123021520294	1	2
ASAH2	t-lymphocytes/immunology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
ASAH2	membrane proteins/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
ASAH2	heme oxygenase-1/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
ASAH2	neutral ceramidase/antagonists &amp; inhibitors	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
ASAH2	HMOX1	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
heterografts/drug effects	vidarabine/analogs &amp; derivatives	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
heterografts/drug effects	trisaccharides/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
heterografts/drug effects	tissue distribution	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
vidarabine/analogs &amp; derivatives	trisaccharides/chemistry	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
vidarabine/analogs &amp; derivatives	tissue distribution	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
HMOX1	tumor suppressor protein p53/metabolism	6.276739991117886e-05	0.00017796190552851575	0.06060606060606061	0.49585123021520294	1	2
HMOX1	t-lymphocytes/immunology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
HMOX1	membrane proteins/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
HMOX1	heme oxygenase-1/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
HMOX1	neutral ceramidase/antagonists &amp; inhibitors	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
trisaccharides/chemistry	tissue distribution	0.0	0.0	0.030303030303030304	0.49585123021520294	1	2
CD44	HSPB1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
CD44	SLC40A1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
HSPB1	SLC40A1	9.36362098968857e-13	2.1035982116529363e-11	0.030303030303030304	0.49585123021520294	1	2
carcinogenesis/immunology	imidazoles/administration &amp; dosage	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
carcinogenesis/immunology	tumor suppressor protein p53/biosynthesis	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
carcinogenesis/immunology	piperazines/administration &amp; dosage	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
carcinogenesis/immunology	immunity innate/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
carcinogenesis/immunology	apoptosis/immunology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
carcinogenesis/immunology	TLR3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
imidazoles/administration &amp; dosage	tumor suppressor protein p53/biosynthesis	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
imidazoles/administration &amp; dosage	piperazines/administration &amp; dosage	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
imidazoles/administration &amp; dosage	immunity innate/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
imidazoles/administration &amp; dosage	apoptosis/immunology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
imidazoles/administration &amp; dosage	TLR3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
neutrophil infiltration	myocardium/immunology	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophil infiltration	toll-like receptor 4/genetics	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophil infiltration	inflammation/drug therapy	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophil infiltration	adaptor proteins vesicular transport/genetics	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophil infiltration	ventricular function left/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophil infiltration	neutrophils/immunology	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophil infiltration	myocardial reperfusion injury/drug therapy	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophil infiltration	TICAM1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophil infiltration	TRIM69	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
tumor suppressor protein p53/biosynthesis	piperazines/administration &amp; dosage	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
tumor suppressor protein p53/biosynthesis	immunity innate/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
tumor suppressor protein p53/biosynthesis	apoptosis/immunology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
tumor suppressor protein p53/biosynthesis	TLR3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
myocardium/immunology	adaptor proteins vesicular transport/genetics	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
myocardium/immunology	ventricular function left/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
myocardium/immunology	neutrophils/immunology	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
myocardium/immunology	myocardial reperfusion injury/drug therapy	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
myocardium/immunology	TICAM1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
myocardium/immunology	TRIM69	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
myocardium/immunology	toll-like receptor 4/genetics	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
myocardium/immunology	inflammation/drug therapy	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
piperazines/administration &amp; dosage	immunity innate/genetics	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
piperazines/administration &amp; dosage	apoptosis/immunology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
piperazines/administration &amp; dosage	TLR3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
immunity innate/genetics	apoptosis/immunology	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
immunity innate/genetics	TLR3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
apoptosis/immunology	TLR3	6.279510245121855e-11	6.844666167182822e-10	0.030303030303030304	0.49585123021520294	1	2
toll-like receptor 4/genetics	inflammation/drug therapy	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
toll-like receptor 4/genetics	adaptor proteins vesicular transport/genetics	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
toll-like receptor 4/genetics	ventricular function left/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
toll-like receptor 4/genetics	neutrophils/immunology	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
toll-like receptor 4/genetics	myocardial reperfusion injury/drug therapy	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
toll-like receptor 4/genetics	TICAM1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
toll-like receptor 4/genetics	TRIM69	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
inflammation/drug therapy	adaptor proteins vesicular transport/genetics	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
inflammation/drug therapy	ventricular function left/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
inflammation/drug therapy	neutrophils/immunology	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
inflammation/drug therapy	myocardial reperfusion injury/drug therapy	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
inflammation/drug therapy	TICAM1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
inflammation/drug therapy	TRIM69	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
tumor suppressor protein p53/metabolism	lymphoma t-cell	8.052230455746212e-07	3.6069580260671387e-06	0.06060606060606061	0.49585123021520294	1	2
tumor suppressor protein p53/metabolism	cisplatin	8.052230455746212e-07	3.6069580260671387e-06	0.06060606060606061	0.49585123021520294	1	2
tumor suppressor protein p53/metabolism	killer cells natural/metabolism	8.052230455746212e-07	3.6069580260671387e-06	0.06060606060606061	0.49585123021520294	1	2
tumor suppressor protein p53/metabolism	membrane proteins/metabolism	6.276739991117886e-05	0.00017796190552851575	0.06060606060606061	0.49585123021520294	1	2
tumor suppressor protein p53/metabolism	diterpenes/pharmacology	8.052230455746212e-07	3.6069580260671387e-06	0.06060606060606061	0.49585123021520294	1	2
tumor suppressor protein p53/metabolism	neutral ceramidase/antagonists &amp; inhibitors	6.276739991117886e-05	0.00017796190552851575	0.06060606060606061	0.49585123021520294	1	2
tumor suppressor protein p53/metabolism	heme oxygenase-1/metabolism	6.276739991117886e-05	0.00017796190552851575	0.06060606060606061	0.49585123021520294	1	2
tumor suppressor protein p53/metabolism	t-lymphocytes/immunology	6.276739991117886e-05	0.00017796190552851575	0.06060606060606061	0.49585123021520294	1	2
tumor suppressor protein p53/metabolism	asparaginase	8.052230455746212e-07	3.6069580260671387e-06	0.06060606060606061	0.49585123021520294	1	2
lymphoma t-cell	diterpenes/pharmacology	3.774758283725532e-15	1.3886392036255303e-13	0.030303030303030304	0.49585123021520294	1	2
lymphoma t-cell	killer cells natural/metabolism	3.774758283725532e-15	1.3886392036255303e-13	0.030303030303030304	0.49585123021520294	1	2
lymphoma t-cell	cisplatin	3.774758283725532e-15	1.3886392036255303e-13	0.030303030303030304	0.49585123021520294	1	2
lymphoma t-cell	asparaginase	3.774758283725532e-15	1.3886392036255303e-13	0.030303030303030304	0.49585123021520294	1	2
adaptor proteins vesicular transport/genetics	TICAM1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
adaptor proteins vesicular transport/genetics	TRIM69	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
adaptor proteins vesicular transport/genetics	ventricular function left/drug effects	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
adaptor proteins vesicular transport/genetics	neutrophils/immunology	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
adaptor proteins vesicular transport/genetics	myocardial reperfusion injury/drug therapy	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
membrane proteins/metabolism	neutral ceramidase/antagonists &amp; inhibitors	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
membrane proteins/metabolism	heme oxygenase-1/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
membrane proteins/metabolism	t-lymphocytes/immunology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
ventricular function left/drug effects	TICAM1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
ventricular function left/drug effects	TRIM69	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
ventricular function left/drug effects	neutrophils/immunology	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
ventricular function left/drug effects	myocardial reperfusion injury/drug therapy	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophils/immunology	TICAM1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophils/immunology	TRIM69	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
neutrophils/immunology	myocardial reperfusion injury/drug therapy	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
myocardial reperfusion injury/drug therapy	TICAM1	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
myocardial reperfusion injury/drug therapy	TRIM69	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
cisplatin	diterpenes/pharmacology	3.774758283725532e-15	1.3886392036255303e-13	0.030303030303030304	0.49585123021520294	1	2
cisplatin	killer cells natural/metabolism	3.774758283725532e-15	1.3886392036255303e-13	0.030303030303030304	0.49585123021520294	1	2
cisplatin	asparaginase	3.774758283725532e-15	1.3886392036255303e-13	0.030303030303030304	0.49585123021520294	1	2
TICAM1	TRIM69	1.676819794127482e-09	1.1920001579993188e-08	0.030303030303030304	0.49585123021520294	1	2
killer cells natural/metabolism	diterpenes/pharmacology	3.774758283725532e-15	1.3886392036255303e-13	0.030303030303030304	0.49585123021520294	1	2
killer cells natural/metabolism	asparaginase	3.774758283725532e-15	1.3886392036255303e-13	0.030303030303030304	0.49585123021520294	1	2
diterpenes/pharmacology	asparaginase	3.774758283725532e-15	1.3886392036255303e-13	0.030303030303030304	0.49585123021520294	1	2
neutral ceramidase/antagonists &amp; inhibitors	heme oxygenase-1/metabolism	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
neutral ceramidase/antagonists &amp; inhibitors	t-lymphocytes/immunology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
heme oxygenase-1/metabolism	t-lymphocytes/immunology	1.9112196392168102e-07	8.857825823960744e-07	0.030303030303030304	0.49585123021520294	1	2
